Share your contact details to receive free updated sample copy/pages of the recently published edition of Vaccines Market Report 2023.
Key Insights from Vaccines Market Report
As per Cognitive Market Research's latest published report, the Global Vaccines market size was USD 68.57 Billion in 2022 and it is forecasted to reach USD 155.39 Billion by 2030. Vaccines Industry's Compound Annual Growth Rate will be 10.8% from 2023 to 2030.
Global Vaccines Market Compound Annual Growth Rate (CAGR) for 2023 to 2030 | 10.8% |
Vaccines Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Vaccines Market Report Description
What is Vaccine?
A preparation that is used to stimulate the body’s immune response against diseases is referred to as a vaccine. Most vaccines are given by needle injection, although some can also be taken by mouth or sprayed into the nose. Immune responses that fight illness are produced when the immune system is stimulated by vaccines. A vaccine typically consists of an agent that resembles disease-causing microbes and is made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. This agent stimulates the immune system to recognize the agent as a threat, destroy it, and further recognize and destroy any microorganisms associated with that agent that it may encounter in the future.
Factors Impacting on Vaccines Market
The increasing prevalence of emerging and re-emerging infectious diseases, and introduction of several vaccination programs by governments across various endemic regions, and the increased sensitivity of the geriatric & pediatric population to lethal diseases are the major driving factors for the growth of the vaccines market. The demand for vaccines is further stimulated by the growing involvement of numerous international organizations, including WHO, UNICEF, World Bank, Bill & Melinda Gates Foundation, etc. in developing suitable immunization facilities in endemic regions.
Further, increasing investment in research and development by the different governments and companies for vaccine preparation will create lucrative opportunities for the vaccine market. However, the high cost of several vaccines per dose limits the vaccine market’s growth. For instance, the cost of the vaccines for hepatitis A/Hepatitis B, Infanrix is higher, which can limit the growth of the market in developing or low-income nations.
Base Year | 2022 |
Historical Data Time Period | 2018-2022 |
Forecast Period | 2023-2030 |
Report Edition | 7th Edition (2023) |
Last Update | Last Updated In April 2023 |
Next Report Edition | June 2023 (Pre-Booking Available) |
Market Forecast/Projection Time Period | 2023-2030 |
Report Format | PDF | PPT | Excel | Word | Bi |
Report ID | CMR611772 |
Vaccines Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)
- 1.1 Global Vaccines Industry Introduction
- 1.2 Objectives of the Study
- 1.3 USP of the Report
- 1.4 Who is this report for?
- 1.5 Designing of Market Scope
- 1.5.1 Vaccines Market Segmentation
- 1.5.1 Vaccines Market Regional Fragmentation
- 1.5.1 Vaccines Market Players
- 1.6 Report Duration
- 1.7 List of Stakeholders
- 2.1 Vaccines Market Report 2023 Research Methodology
- 2.2 Systematic Research Approach
- 2.2.1 Primary Research
- 2.2.1.1 Key Data from Primary
- 2.2.1.2 Primary Interviews with Experts
- 2.2.1.3 Key Industry Insights
- 2.2.1.4 Questionnaire
At Cognitive Market Research, we have designed questionnaire focused on Vaccines Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Vaccines industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
- 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
- 2.2.2.1 Key Data from Secondary
- 2.2.2.2 Paid Sources
- 2.2.2.3 Public Sources
- 2.2.1 Primary Research
- 2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
- 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
- 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 2.3.1 Top-Down Approach
- 2.4 Market Breakdown and Data Triangulation
- 2.5 Research Assumptions
- 3.1 Global Vaccines Market Size 2018 – 2030, (USD Million)
- 3.2 Global Vaccines Value, Absolute & Opportunity Analysis
- 3.3 Global Vaccines Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
- 3.4 Global Vaccines Market Statistics 2022: Snapshot
- 4.1 Vaccines Introduction
- 4.2 Global Vaccines Market Statistics by Regions (2018-2030)
- 4.2.1 North America Vaccines Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Vaccines Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Vaccines Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Vaccines Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Vaccines Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.3 Global Vaccines Market Size (2018-2030)
- 4.3.1 Global Vaccines Revenue Status and Outlook (2018-2030)
- 4.4 Global Vaccines Market Price Analysis by Regions (2018-2030)
- 5.1 Global Vaccines Market Revenue and Share by Manufacturers (2018-2022)
- 5.2 Global Vaccines Industry Mergers and Acquisition Analysis
- 5.3 Global Vaccines New Launches Analysis
- 5.4 Company Categorization
- 5.5 Global Vaccines Top Winning Strategies, by Manufacturers (2018-2022)
- 7.1 Vaccines Industrial Dynamics
- 7.1.1 Global Vaccines Market Drivers
- 7.1.2 Global Vaccines Market Restrains
- 7.1.3 Global Vaccines Market Opportunities
- 7.1.4 Global Vaccines Market Trends
- 7.2 Vaccines Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
- 7.3 PESTEL Analysis for Vaccines Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
- 7.4 Porter’s Five Forces Analysis for Vaccines Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
- 7.5 COVID-19 Impact on Vaccines Industry
- 7.4.1 Overall Impact of COVID-19 on Vaccines Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
- 7.6 Consumer Preference Analysis for Vaccines Market
- 7.7 Patent Analysis of Vaccines
- 7.8 Vaccines Industrial Chain Analysis
- 7.9 Manufacturing Cost Analysis
- 8.1 GSK
- 8.1.1 GSK Company Basic Information, and Sales Area
- 8.1.2 GSK Business Segment/ Overview
- 8.1.3 GSK Financials
- 8.1.3.1 Investment in Research and Development
- 8.1.3.2 GSK Sales Revenue (2018-2022)
- 8.1.3.3 GSK Market Share (2018-2022)
- 8.1.4 GSK Recent Developments
- 8.1.5 GSK Business Strategy
- 8.1.6 GSK Management Change
- 8.1.7 GSK SWOT Analysis
- 8.1.7.1 Strength
- 8.1.7.2 Weakness
- 8.1.7.3 Opportunity
- 8.1.7.4 Threats
- 8.1.8 GSK COVID-19 Impact Analysis
- 8.2 Sanofi
- 8.2.1 Sanofi Company Basic Information, and Sales Area
- 8.2.2 Sanofi Business Segment/ Overview
- 8.2.3 Sanofi Financials
- 8.2.3.1 Investment in Research and Development
- 8.2.3.2 Sanofi Sales Revenue (2018-2022)
- 8.2.3.3 Sanofi Market Share (2018-2022)
- 8.2.4 Sanofi Recent Developments
- 8.2.5 Sanofi Business Strategy
- 8.2.6 Sanofi Management Change
- 8.2.7 Sanofi SWOT Analysis
- 8.2.7.1 Strength
- 8.2.7.2 Weakness
- 8.2.7.3 Opportunity
- 8.2.7.4 Threats
- 8.2.8 Sanofi COVID-19 Impact Analysis
- 8.3 Merck
- 8.3.1 Merck Company Basic Information, and Sales Area
- 8.3.2 Merck Business Segment/ Overview
- 8.3.3 Merck Financials
- 8.3.3.1 Investment in Research and Development
- 8.3.3.2 Merck Sales Revenue (2018-2022)
- 8.3.3.3 Merck Market Share (2018-2022)
- 8.3.4 Merck Recent Developments
- 8.3.5 Merck Business Strategy
- 8.3.6 Merck Management Change
- 8.3.7 Merck SWOT Analysis
- 8.3.7.1 Strength
- 8.3.7.2 Weakness
- 8.3.7.3 Opportunity
- 8.3.7.4 Threats
- 8.3.8 Merck COVID-19 Impact Analysis
- 8.4 Pfizer
- 8.4.1 Pfizer Company Basic Information, and Sales Area
- 8.4.2 Pfizer Business Segment/ Overview
- 8.4.3 Pfizer Financials
- 8.4.3.1 Investment in Research and Development
- 8.4.3.2 Pfizer Sales Revenue (2018-2022)
- 8.4.3.3 Pfizer Market Share (2018-2022)
- 8.4.4 Pfizer Recent Developments
- 8.4.5 Pfizer Business Strategy
- 8.4.6 Pfizer Management Change
- 8.4.7 Pfizer SWOT Analysis
- 8.4.7.1 Strength
- 8.4.7.2 Weakness
- 8.4.7.3 Opportunity
- 8.4.7.4 Threats
- 8.4.8 Pfizer COVID-19 Impact Analysis
- 8.5 Novartis(GSK)
- 8.5.1 Novartis(GSK) Company Basic Information, and Sales Area
- 8.5.2 Novartis(GSK) Business Segment/ Overview
- 8.5.3 Novartis(GSK) Financials
- 8.5.3.1 Investment in Research and Development
- 8.5.3.2 Novartis(GSK) Sales Revenue (2018-2022)
- 8.5.3.3 Novartis(GSK) Market Share (2018-2022)
- 8.5.4 Novartis(GSK) Recent Developments
- 8.5.5 Novartis(GSK) Business Strategy
- 8.5.6 Novartis(GSK) Management Change
- 8.5.7 Novartis(GSK) SWOT Analysis
- 8.5.7.1 Strength
- 8.5.7.2 Weakness
- 8.5.7.3 Opportunity
- 8.5.7.4 Threats
- 8.5.8 Novartis(GSK) COVID-19 Impact Analysis
- 8.6 CSL
- 8.6.1 CSL Company Basic Information, and Sales Area
- 8.6.2 CSL Business Segment/ Overview
- 8.6.3 CSL Financials
- 8.6.3.1 Investment in Research and Development
- 8.6.3.2 CSL Sales Revenue (2018-2022)
- 8.6.3.3 CSL Market Share (2018-2022)
- 8.6.4 CSL Recent Developments
- 8.6.5 CSL Business Strategy
- 8.6.6 CSL Management Change
- 8.6.7 CSL SWOT Analysis
- 8.6.7.1 Strength
- 8.6.7.2 Weakness
- 8.6.7.3 Opportunity
- 8.6.7.4 Threats
- 8.6.8 CSL COVID-19 Impact Analysis
- 8.7 MedImmune  LLC
- 8.7.1 MedImmune  LLC Company Basic Information, and Sales Area
- 8.7.2 MedImmune  LLC Business Segment/ Overview
- 8.7.3 MedImmune  LLC Financials
- 8.7.3.1 Investment in Research and Development
- 8.7.3.2 MedImmune  LLC Sales Revenue (2018-2022)
- 8.7.3.3 MedImmune  LLC Market Share (2018-2022)
- 8.7.4 MedImmune  LLC Recent Developments
- 8.7.5 MedImmune  LLC Business Strategy
- 8.7.6 MedImmune  LLC Management Change
- 8.7.7 MedImmune  LLC SWOT Analysis
- 8.7.7.1 Strength
- 8.7.7.2 Weakness
- 8.7.7.3 Opportunity
- 8.7.7.4 Threats
- 8.7.8 MedImmune  LLC COVID-19 Impact Analysis
- 8.8 J&J Crucell
- 8.8.1 J&J Crucell Company Basic Information, and Sales Area
- 8.8.2 J&J Crucell Business Segment/ Overview
- 8.8.3 J&J Crucell Financials
- 8.8.3.1 Investment in Research and Development
- 8.8.3.2 J&J Crucell Sales Revenue (2018-2022)
- 8.8.3.3 J&J Crucell Market Share (2018-2022)
- 8.8.4 J&J Crucell Recent Developments
- 8.8.5 J&J Crucell Business Strategy
- 8.8.6 J&J Crucell Management Change
- 8.8.7 J&J Crucell SWOT Analysis
- 8.8.7.1 Strength
- 8.8.7.2 Weakness
- 8.8.7.3 Opportunity
- 8.8.7.4 Threats
- 8.8.8 J&J Crucell COVID-19 Impact Analysis
- 8.9 China National Biotec
- 8.9.1 China National Biotec Company Basic Information, and Sales Area
- 8.9.2 China National Biotec Business Segment/ Overview
- 8.9.3 China National Biotec Financials
- 8.9.3.1 Investment in Research and Development
- 8.9.3.2 China National Biotec Sales Revenue (2018-2022)
- 8.9.3.3 China National Biotec Market Share (2018-2022)
- 8.9.4 China National Biotec Recent Developments
- 8.9.5 China National Biotec Business Strategy
- 8.9.6 China National Biotec Management Change
- 8.9.7 China National Biotec SWOT Analysis
- 8.9.7.1 Strength
- 8.9.7.2 Weakness
- 8.9.7.3 Opportunity
- 8.9.7.4 Threats
- 8.9.8 China National Biotec COVID-19 Impact Analysis
- 8.10 Tiantan
- 8.10.1 Tiantan Company Basic Information, and Sales Area
- 8.10.2 Tiantan Business Segment/ Overview
- 8.10.3 Tiantan Financials
- 8.10.3.1 Investment in Research and Development
- 8.10.3.2 Tiantan Sales Revenue (2018-2022)
- 8.10.3.3 Tiantan Market Share (2018-2022)
- 8.10.4 Tiantan Recent Developments
- 8.10.5 Tiantan Business Strategy
- 8.10.6 Tiantan Management Change
- 8.10.7 Tiantan SWOT Analysis
- 8.10.7.1 Strength
- 8.10.7.2 Weakness
- 8.10.7.3 Opportunity
- 8.10.7.4 Threats
- 8.10.8 Tiantan COVID-19 Impact Analysis
- 8.11 Hualan
- 8.11.1 Hualan Company Basic Information, and Sales Area
- 8.11.2 Hualan Business Segment/ Overview
- 8.11.3 Hualan Financials
- 8.11.3.1 Investment in Research and Development
- 8.11.3.2 Hualan Sales Revenue (2018-2022)
- 8.11.3.3 Hualan Market Share (2018-2022)
- 8.11.4 Hualan Recent Developments
- 8.11.5 Hualan Business Strategy
- 8.11.6 Hualan Management Change
- 8.11.7 Hualan SWOT Analysis
- 8.11.7.1 Strength
- 8.11.7.2 Weakness
- 8.11.7.3 Opportunity
- 8.11.7.4 Threats
- 8.11.8 Hualan COVID-19 Impact Analysis
- 8.12 Kangtai
- 8.12.1 Kangtai Company Basic Information, and Sales Area
- 8.12.2 Kangtai Business Segment/ Overview
- 8.12.3 Kangtai Financials
- 8.12.3.1 Investment in Research and Development
- 8.12.3.2 Kangtai Sales Revenue (2018-2022)
- 8.12.3.3 Kangtai Market Share (2018-2022)
- 8.12.4 Kangtai Recent Developments
- 8.12.5 Kangtai Business Strategy
- 8.12.6 Kangtai Management Change
- 8.12.7 Kangtai SWOT Analysis
- 8.12.7.1 Strength
- 8.12.7.2 Weakness
- 8.12.7.3 Opportunity
- 8.12.7.4 Threats
- 8.12.8 Kangtai COVID-19 Impact Analysis
- 8.13 Hissen
- 8.13.1 Hissen Company Basic Information, and Sales Area
- 8.13.2 Hissen Business Segment/ Overview
- 8.13.3 Hissen Financials
- 8.13.3.1 Investment in Research and Development
- 8.13.3.2 Hissen Sales Revenue (2018-2022)
- 8.13.3.3 Hissen Market Share (2018-2022)
- 8.13.4 Hissen Recent Developments
- 8.13.5 Hissen Business Strategy
- 8.13.6 Hissen Management Change
- 8.13.7 Hissen SWOT Analysis
- 8.13.7.1 Strength
- 8.13.7.2 Weakness
- 8.13.7.3 Opportunity
- 8.13.7.4 Threats
- 8.13.8 Hissen COVID-19 Impact Analysis
- 8.14 Jintan
- 8.14.1 Jintan Company Basic Information, and Sales Area
- 8.14.2 Jintan Business Segment/ Overview
- 8.14.3 Jintan Financials
- 8.14.3.1 Investment in Research and Development
- 8.14.3.2 Jintan Sales Revenue (2018-2022)
- 8.14.3.3 Jintan Market Share (2018-2022)
- 8.14.4 Jintan Recent Developments
- 8.14.5 Jintan Business Strategy
- 8.14.6 Jintan Management Change
- 8.14.7 Jintan SWOT Analysis
- 8.14.7.1 Strength
- 8.14.7.2 Weakness
- 8.14.7.3 Opportunity
- 8.14.7.4 Threats
- 8.14.8 Jintan COVID-19 Impact Analysis
- 9.1 Detailed Qualitative Analysis
- 9.2 Global Vaccines Revenue and Share (%) by Type (2018-2030)
- 9.2.1 Combination Vaccines Market Size
- 9.2.1.1 Global Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 9.2.1.2 Vaccines Market for Combination Vaccines, by Country (2021 Vs 2024)
- 9.2.2 Monovaccines Market Size
- 9.2.2.1 Global Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 9.2.2.2 Vaccines Market for Monovaccines, by Country (2021 Vs 2024)
- 9.2.1 Combination Vaccines Market Size
- 10.1 Detailed Qualitative Analysis
- 10.2 Global Vaccines Revenue and Share (%) by Application (2018-2030)
- 10.2.1 Community Hospitals Market Size
- 10.2.1.1 Global Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 10.2.1.2 Vaccines Market for Community Hospitals, by Country (2021 Vs 2024)
- 10.2.2 Hospitals Market Size
- 10.2.2.1 Global Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 10.2.2.2 Vaccines Market for Hospitals, by Country (2021 Vs 2024)
- 10.2.3 Specialty Centres Market Size
- 10.2.3.1 Global Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 10.2.3.2 Vaccines Market for Specialty Centres, by Country (2021 Vs 2024)
- 10.2.4 Clinics Market Size
- 10.2.4.1 Global Clinics Market Share and Revenue (USD Million) for 2018-2030
- 10.2.4.2 Vaccines Market for Clinics, by Country (2021 Vs 2024)
- 10.2.5 Others Market Size
- 10.2.5.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 10.2.5.2 Vaccines Market for Others, by Country (2021 Vs 2024)
- 10.2.1 Community Hospitals Market Size
- 11.1 Detailed Qualitative Analysis
- 11.2 Global Vaccines Revenue and Share (%) by Technology (2018-2030)
- 11.2.1 Recombinant Vaccines Market Size
- 11.2.1.1 Global Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 11.2.1.2 Vaccines Market for Recombinant Vaccines, by Country (2021 Vs 2024)
- 11.2.2 Conjugate Vaccines Market Size
- 11.2.2.1 Global Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 11.2.2.2 Vaccines Market for Conjugate Vaccines, by Country (2021 Vs 2024)
- 11.2.3 Live-Attenuated Vaccines Market Size
- 11.2.3.1 Global Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 11.2.3.2 Vaccines Market for Live-Attenuated Vaccines, by Country (2021 Vs 2024)
- 11.2.4 Inactivated Vaccines Market Size
- 11.2.4.1 Global Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 11.2.4.2 Vaccines Market for Inactivated Vaccines, by Country (2021 Vs 2024)
- 11.2.5 Toxoid Vaccines Market Size
- 11.2.5.1 Global Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 11.2.5.2 Vaccines Market for Toxoid Vaccines, by Country (2021 Vs 2024)
- 11.2.1 Recombinant Vaccines Market Size
- 12.1 Detailed Qualitative Analysis
- 12.2 Global Vaccines Revenue and Share (%) by Age Group (2018-2030)
- 12.2.1 Pediatric Vaccine Market Size
- 12.2.1.1 Global Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.2.1.2 Vaccines Market for Pediatric Vaccine, by Country (2021 Vs 2024)
- 12.2.2 Adult Vaccine Market Size
- 12.2.2.1 Global Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 12.2.2.2 Vaccines Market for Adult Vaccine, by Country (2021 Vs 2024)
- 12.2.1 Pediatric Vaccine Market Size
- 13.1 Detailed Qualitative Analysis
- 13.2 Global Vaccines Revenue and Share (%) by Type of Diseases (2018-2030)
- 13.2.1 Pneumococcal Disease Market Size
- 13.2.1.1 Global Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 13.2.1.2 Vaccines Market for Pneumococcal Disease, by Country (2021 Vs 2024)
- 13.2.2 Measles Market Size
- 13.2.2.1 Global Measles Market Share and Revenue (USD Million) for 2018-2030
- 13.2.2.2 Vaccines Market for Measles, by Country (2021 Vs 2024)
- 13.2.3 Mumps Market Size
- 13.2.3.1 Global Mumps Market Share and Revenue (USD Million) for 2018-2030
- 13.2.3.2 Vaccines Market for Mumps, by Country (2021 Vs 2024)
- 13.2.4 Varicella Market Size
- 13.2.4.1 Global Varicella Market Share and Revenue (USD Million) for 2018-2030
- 13.2.4.2 Vaccines Market for Varicella, by Country (2021 Vs 2024)
- 13.2.5 DPT Market Size
- 13.2.5.1 Global DPT Market Share and Revenue (USD Million) for 2018-2030
- 13.2.5.2 Vaccines Market for DPT, by Country (2021 Vs 2024)
- 13.2.6 Hepatitis Market Size
- 13.2.6.1 Global Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.6.2 Vaccines Market for Hepatitis, by Country (2021 Vs 2024)
- 13.2.7 Influenza Market Size
- 13.2.7.1 Global Influenza Market Share and Revenue (USD Million) for 2018-2030
- 13.2.7.2 Vaccines Market for Influenza, by Country (2021 Vs 2024)
- 13.2.8 Typhoid Market Size
- 13.2.8.1 Global Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 13.2.8.2 Vaccines Market for Typhoid, by Country (2021 Vs 2024)
- 13.2.9 Meningococcal Market Size
- 13.2.9.1 Global Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 13.2.9.2 Vaccines Market for Meningococcal, by Country (2021 Vs 2024)
- 13.2.10 Rabies Market Size
- 13.2.10.1 Global Rabies Market Share and Revenue (USD Million) for 2018-2030
- 13.2.10.2 Vaccines Market for Rabies, by Country (2021 Vs 2024)
- 13.2.11 Japanese Encephalitis Market Size
- 13.2.11.1 Global Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 13.2.11.2 Vaccines Market for Japanese Encephalitis, by Country (2021 Vs 2024)
- 13.2.12 Yellow Fever Market Size
- 13.2.12.1 Global Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 13.2.12.2 Vaccines Market for Yellow Fever, by Country (2021 Vs 2024)
- 13.2.13 Others Market Size
- 13.2.13.1 Global Others Market Share and Revenue (USD Million) for 2018-2030
- 13.2.13.2 Vaccines Market for Others, by Country (2021 Vs 2024)
- 13.2.1 Pneumococcal Disease Market Size
- 14.1 Detailed Qualitative Analysis
- 14.2 Global Vaccines Revenue and Share (%) by Route of Administration (2018-2030)
- 14.2.1 Injectable Market Size
- 14.2.1.1 Global Injectable Market Share and Revenue (USD Million) for 2018-2030
- 14.2.1.2 Vaccines Market for Injectable, by Country (2021 Vs 2024)
- 14.2.2 Oral Market Size
- 14.2.2.1 Global Oral Market Share and Revenue (USD Million) for 2018-2030
- 14.2.2.2 Vaccines Market for Oral, by Country (2021 Vs 2024)
- 14.2.3 Nasal Market Size
- 14.2.3.1 Global Nasal Market Share and Revenue (USD Million) for 2018-2030
- 14.2.3.2 Vaccines Market for Nasal, by Country (2021 Vs 2024)
- 14.2.1 Injectable Market Size
- 15.1 Detailed Qualitative Analysis
- 15.2 Global Vaccines Market Revenue by Region (2018-2030)
- 15.3 Global Vaccines Market Share (%) by Region (2018-2030)
- 16.1 North America
- 16.1.1 North America Vaccines Market Trends and Analysis
- 16.1.2 North America Vaccines Market by Country, 2018-2030
- 16.1.3 North America Vaccines Market Attractiveness Analysis by Country
- 16.2 North America Vaccines Market Size (2018-2030)
- 16.2.1 North America Vaccines Market (USD Million) by Type (2018-2030)
- 16.2.1.1 Combination Vaccines
- 16.2.1.1.1 North America Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.2 Monovaccines
- 16.2.1.2.1 North America Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.1.1 Combination Vaccines
- 16.2.2 North America Vaccines Market (USD Million) by Application (2018-2030)
- 16.2.2.1 Community Hospitals
- 16.2.2.1.1 North America Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.2 Hospitals
- 16.2.2.2.1 North America Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.3 Specialty Centres
- 16.2.2.3.1 North America Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.4 Clinics
- 16.2.2.4.1 North America Clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.5 Others
- 16.2.2.5.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.2.1 Community Hospitals
- 16.2.3 North America Vaccines Market (USD Million) by Technology (2018-2030)
- 16.2.3.1 Recombinant Vaccines
- 16.2.3.1.1 North America Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.2 Conjugate Vaccines
- 16.2.3.2.1 North America Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.3 Live-Attenuated Vaccines
- 16.2.3.3.1 North America Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.4 Inactivated Vaccines
- 16.2.3.4.1 North America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.5 Toxoid Vaccines
- 16.2.3.5.1 North America Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.2.3.1 Recombinant Vaccines
- 16.2.4 North America Vaccines Market (USD Million) by Age Group (2018-2030)
- 16.2.4.1 Pediatric Vaccine
- 16.2.4.1.1 North America Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.2 Adult Vaccine
- 16.2.4.2.1 North America Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.2.4.1 Pediatric Vaccine
- 16.2.5 North America Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 16.2.5.1 Pneumococcal Disease
- 16.2.5.1.1 North America Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.2 Measles
- 16.2.5.2.1 North America Measles Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.3 Mumps
- 16.2.5.3.1 North America Mumps Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.4 Varicella
- 16.2.5.4.1 North America Varicella Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.5 DPT
- 16.2.5.5.1 North America DPT Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.6 Hepatitis
- 16.2.5.6.1 North America Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.7 Influenza
- 16.2.5.7.1 North America Influenza Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.8 Typhoid
- 16.2.5.8.1 North America Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.9 Meningococcal
- 16.2.5.9.1 North America Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.10 Rabies
- 16.2.5.10.1 North America Rabies Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.11 Japanese Encephalitis
- 16.2.5.11.1 North America Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.12 Yellow Fever
- 16.2.5.12.1 North America Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.13 Others
- 16.2.5.13.1 North America Others Market Share and Revenue (USD Million) for 2018-2030
- 16.2.5.1 Pneumococcal Disease
- 16.2.6 North America Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 16.2.6.1 Injectable
- 16.2.6.1.1 North America Injectable Market Share and Revenue (USD Million) for 2018-2030
- 16.2.6.2 Oral
- 16.2.6.2.1 North America Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.2.6.3 Nasal
- 16.2.6.3.1 North America Nasal Market Share and Revenue (USD Million) for 2018-2030
- 16.2.6.1 Injectable
- 16.2.1 North America Vaccines Market (USD Million) by Type (2018-2030)
- 16.3 United States Vaccines Market Size (2018-2030)
- 16.3.1 United States Vaccines Market (USD Million) by Type (2018-2030)
- 16.3.1.1 Combination Vaccines
- 16.3.1.1.1 United States Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.2 Monovaccines
- 16.3.1.2.1 United States Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.1.1 Combination Vaccines
- 16.3.2 United States Vaccines Market (USD Million) by Application (2018-2030)
- 16.3.2.1 Community Hospitals
- 16.3.2.1.1 United States Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.2 Hospitals
- 16.3.2.2.1 United States Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.3 Specialty Centres
- 16.3.2.3.1 United States Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.4 Clinics
- 16.3.2.4.1 United States Clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.5 Others
- 16.3.2.5.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.2.1 Community Hospitals
- 16.3.3 United States Vaccines Market (USD Million) by Technology (2018-2030)
- 16.3.3.1 Recombinant Vaccines
- 16.3.3.1.1 United States Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.2 Conjugate Vaccines
- 16.3.3.2.1 United States Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.3 Live-Attenuated Vaccines
- 16.3.3.3.1 United States Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.4 Inactivated Vaccines
- 16.3.3.4.1 United States Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.5 Toxoid Vaccines
- 16.3.3.5.1 United States Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.3.3.1 Recombinant Vaccines
- 16.3.4 United States Vaccines Market (USD Million) by Age Group (2018-2030)
- 16.3.4.1 Pediatric Vaccine
- 16.3.4.1.1 United States Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.2 Adult Vaccine
- 16.3.4.2.1 United States Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.3.4.1 Pediatric Vaccine
- 16.3.5 United States Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 16.3.5.1 Pneumococcal Disease
- 16.3.5.1.1 United States Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.2 Measles
- 16.3.5.2.1 United States Measles Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.3 Mumps
- 16.3.5.3.1 United States Mumps Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.4 Varicella
- 16.3.5.4.1 United States Varicella Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.5 DPT
- 16.3.5.5.1 United States DPT Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.6 Hepatitis
- 16.3.5.6.1 United States Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.7 Influenza
- 16.3.5.7.1 United States Influenza Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.8 Typhoid
- 16.3.5.8.1 United States Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.9 Meningococcal
- 16.3.5.9.1 United States Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.10 Rabies
- 16.3.5.10.1 United States Rabies Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.11 Japanese Encephalitis
- 16.3.5.11.1 United States Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.12 Yellow Fever
- 16.3.5.12.1 United States Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.13 Others
- 16.3.5.13.1 United States Others Market Share and Revenue (USD Million) for 2018-2030
- 16.3.5.1 Pneumococcal Disease
- 16.3.6 United States Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 16.3.6.1 Injectable
- 16.3.6.1.1 United States Injectable Market Share and Revenue (USD Million) for 2018-2030
- 16.3.6.2 Oral
- 16.3.6.2.1 United States Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.3.6.3 Nasal
- 16.3.6.3.1 United States Nasal Market Share and Revenue (USD Million) for 2018-2030
- 16.3.6.1 Injectable
- 16.3.1 United States Vaccines Market (USD Million) by Type (2018-2030)
- 16.4 Canada Vaccines Market Size (2018-2030)
- 16.4.1 Canada Vaccines Market (USD Million) by Type (2018-2030)
- 16.4.1.1 Combination Vaccines
- 16.4.1.1.1 Canada Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.2 Monovaccines
- 16.4.1.2.1 Canada Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.1.1 Combination Vaccines
- 16.4.2 Canada Vaccines Market (USD Million) by Application (2018-2030)
- 16.4.2.1 Community Hospitals
- 16.4.2.1.1 Canada Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.2 Hospitals
- 16.4.2.2.1 Canada Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.3 Specialty Centres
- 16.4.2.3.1 Canada Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.4 Clinics
- 16.4.2.4.1 Canada Clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.5 Others
- 16.4.2.5.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.2.1 Community Hospitals
- 16.4.3 Canada Vaccines Market (USD Million) by Technology (2018-2030)
- 16.4.3.1 Recombinant Vaccines
- 16.4.3.1.1 Canada Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.2 Conjugate Vaccines
- 16.4.3.2.1 Canada Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.3 Live-Attenuated Vaccines
- 16.4.3.3.1 Canada Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.4 Inactivated Vaccines
- 16.4.3.4.1 Canada Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.5 Toxoid Vaccines
- 16.4.3.5.1 Canada Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.4.3.1 Recombinant Vaccines
- 16.4.4 Canada Vaccines Market (USD Million) by Age Group (2018-2030)
- 16.4.4.1 Pediatric Vaccine
- 16.4.4.1.1 Canada Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.2 Adult Vaccine
- 16.4.4.2.1 Canada Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.4.4.1 Pediatric Vaccine
- 16.4.5 Canada Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 16.4.5.1 Pneumococcal Disease
- 16.4.5.1.1 Canada Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.2 Measles
- 16.4.5.2.1 Canada Measles Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.3 Mumps
- 16.4.5.3.1 Canada Mumps Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.4 Varicella
- 16.4.5.4.1 Canada Varicella Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.5 DPT
- 16.4.5.5.1 Canada DPT Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.6 Hepatitis
- 16.4.5.6.1 Canada Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.7 Influenza
- 16.4.5.7.1 Canada Influenza Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.8 Typhoid
- 16.4.5.8.1 Canada Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.9 Meningococcal
- 16.4.5.9.1 Canada Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.10 Rabies
- 16.4.5.10.1 Canada Rabies Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.11 Japanese Encephalitis
- 16.4.5.11.1 Canada Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.12 Yellow Fever
- 16.4.5.12.1 Canada Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.13 Others
- 16.4.5.13.1 Canada Others Market Share and Revenue (USD Million) for 2018-2030
- 16.4.5.1 Pneumococcal Disease
- 16.4.6 Canada Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 16.4.6.1 Injectable
- 16.4.6.1.1 Canada Injectable Market Share and Revenue (USD Million) for 2018-2030
- 16.4.6.2 Oral
- 16.4.6.2.1 Canada Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.4.6.3 Nasal
- 16.4.6.3.1 Canada Nasal Market Share and Revenue (USD Million) for 2018-2030
- 16.4.6.1 Injectable
- 16.4.1 Canada Vaccines Market (USD Million) by Type (2018-2030)
- 16.5 Mexico Vaccines Market Size (2018-2030)
- 16.5.1 Mexico Vaccines Market (USD Million) by Type (2018-2030)
- 16.5.1.1 Combination Vaccines
- 16.5.1.1.1 Mexico Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.2 Monovaccines
- 16.5.1.2.1 Mexico Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.1.1 Combination Vaccines
- 16.5.2 Mexico Vaccines Market (USD Million) by Application (2018-2030)
- 16.5.2.1 Community Hospitals
- 16.5.2.1.1 Mexico Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.2 Hospitals
- 16.5.2.2.1 Mexico Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.3 Specialty Centres
- 16.5.2.3.1 Mexico Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.4 Clinics
- 16.5.2.4.1 Mexico Clinics Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.5 Others
- 16.5.2.5.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.2.1 Community Hospitals
- 16.5.3 Mexico Vaccines Market (USD Million) by Technology (2018-2030)
- 16.5.3.1 Recombinant Vaccines
- 16.5.3.1.1 Mexico Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.2 Conjugate Vaccines
- 16.5.3.2.1 Mexico Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.3 Live-Attenuated Vaccines
- 16.5.3.3.1 Mexico Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.4 Inactivated Vaccines
- 16.5.3.4.1 Mexico Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.5 Toxoid Vaccines
- 16.5.3.5.1 Mexico Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 16.5.3.1 Recombinant Vaccines
- 16.5.4 Mexico Vaccines Market (USD Million) by Age Group (2018-2030)
- 16.5.4.1 Pediatric Vaccine
- 16.5.4.1.1 Mexico Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.2 Adult Vaccine
- 16.5.4.2.1 Mexico Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 16.5.4.1 Pediatric Vaccine
- 16.5.5 Mexico Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 16.5.5.1 Pneumococcal Disease
- 16.5.5.1.1 Mexico Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.2 Measles
- 16.5.5.2.1 Mexico Measles Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.3 Mumps
- 16.5.5.3.1 Mexico Mumps Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.4 Varicella
- 16.5.5.4.1 Mexico Varicella Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.5 DPT
- 16.5.5.5.1 Mexico DPT Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.6 Hepatitis
- 16.5.5.6.1 Mexico Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.7 Influenza
- 16.5.5.7.1 Mexico Influenza Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.8 Typhoid
- 16.5.5.8.1 Mexico Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.9 Meningococcal
- 16.5.5.9.1 Mexico Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.10 Rabies
- 16.5.5.10.1 Mexico Rabies Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.11 Japanese Encephalitis
- 16.5.5.11.1 Mexico Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.12 Yellow Fever
- 16.5.5.12.1 Mexico Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.13 Others
- 16.5.5.13.1 Mexico Others Market Share and Revenue (USD Million) for 2018-2030
- 16.5.5.1 Pneumococcal Disease
- 16.5.6 Mexico Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 16.5.6.1 Injectable
- 16.5.6.1.1 Mexico Injectable Market Share and Revenue (USD Million) for 2018-2030
- 16.5.6.2 Oral
- 16.5.6.2.1 Mexico Oral Market Share and Revenue (USD Million) for 2018-2030
- 16.5.6.3 Nasal
- 16.5.6.3.1 Mexico Nasal Market Share and Revenue (USD Million) for 2018-2030
- 16.5.6.1 Injectable
- 16.5.1 Mexico Vaccines Market (USD Million) by Type (2018-2030)
- 17.1 Europe
- 17.1.1 Europe Vaccines Market Trends and Analysis
- 17.1.2 Europe Vaccines Market by Country, 2018-2030
- 17.1.3 Europe Vaccines Market Attractiveness Analysis by Country
- 17.2 Europe Vaccines Market Size (2018-2030)
- 17.2.1 Europe Vaccines Market (USD Million) by Type (2018-2030)
- 17.2.1.1 Combination Vaccines
- 17.2.1.1.1 Europe Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.2 Monovaccines
- 17.2.1.2.1 Europe Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.1.1 Combination Vaccines
- 17.2.2 Europe Vaccines Market (USD Million) by Application (2018-2030)
- 17.2.2.1 Community Hospitals
- 17.2.2.1.1 Europe Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.2 Hospitals
- 17.2.2.2.1 Europe Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.3 Specialty Centres
- 17.2.2.3.1 Europe Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.4 Clinics
- 17.2.2.4.1 Europe Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.5 Others
- 17.2.2.5.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.2.1 Community Hospitals
- 17.2.3 Europe Vaccines Market (USD Million) by Technology (2018-2030)
- 17.2.3.1 Recombinant Vaccines
- 17.2.3.1.1 Europe Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.2 Conjugate Vaccines
- 17.2.3.2.1 Europe Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.3 Live-Attenuated Vaccines
- 17.2.3.3.1 Europe Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.4 Inactivated Vaccines
- 17.2.3.4.1 Europe Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.5 Toxoid Vaccines
- 17.2.3.5.1 Europe Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.2.3.1 Recombinant Vaccines
- 17.2.4 Europe Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.2.4.1 Pediatric Vaccine
- 17.2.4.1.1 Europe Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.2 Adult Vaccine
- 17.2.4.2.1 Europe Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.2.4.1 Pediatric Vaccine
- 17.2.5 Europe Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.2.5.1 Pneumococcal Disease
- 17.2.5.1.1 Europe Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.2 Measles
- 17.2.5.2.1 Europe Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.3 Mumps
- 17.2.5.3.1 Europe Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.4 Varicella
- 17.2.5.4.1 Europe Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.5 DPT
- 17.2.5.5.1 Europe DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.6 Hepatitis
- 17.2.5.6.1 Europe Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.7 Influenza
- 17.2.5.7.1 Europe Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.8 Typhoid
- 17.2.5.8.1 Europe Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.9 Meningococcal
- 17.2.5.9.1 Europe Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.10 Rabies
- 17.2.5.10.1 Europe Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.11 Japanese Encephalitis
- 17.2.5.11.1 Europe Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.12 Yellow Fever
- 17.2.5.12.1 Europe Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.13 Others
- 17.2.5.13.1 Europe Others Market Share and Revenue (USD Million) for 2018-2030
- 17.2.5.1 Pneumococcal Disease
- 17.2.6 Europe Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.2.6.1 Injectable
- 17.2.6.1.1 Europe Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.2.6.2 Oral
- 17.2.6.2.1 Europe Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.2.6.3 Nasal
- 17.2.6.3.1 Europe Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.2.6.1 Injectable
- 17.2.1 Europe Vaccines Market (USD Million) by Type (2018-2030)
- 17.3 United Kingdom Vaccines Market Size (2018-2030)
- 17.3.1 United Kingdom Vaccines Market (USD Million) by Type (2018-2030)
- 17.3.1.1 Combination Vaccines
- 17.3.1.1.1 United Kingdom Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.2 Monovaccines
- 17.3.1.2.1 United Kingdom Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.1.1 Combination Vaccines
- 17.3.2 United Kingdom Vaccines Market (USD Million) by Application (2018-2030)
- 17.3.2.1 Community Hospitals
- 17.3.2.1.1 United Kingdom Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.2 Hospitals
- 17.3.2.2.1 United Kingdom Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.3 Specialty Centres
- 17.3.2.3.1 United Kingdom Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.4 Clinics
- 17.3.2.4.1 United Kingdom Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.5 Others
- 17.3.2.5.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.2.1 Community Hospitals
- 17.3.3 United Kingdom Vaccines Market (USD Million) by Technology (2018-2030)
- 17.3.3.1 Recombinant Vaccines
- 17.3.3.1.1 United Kingdom Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.2 Conjugate Vaccines
- 17.3.3.2.1 United Kingdom Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.3 Live-Attenuated Vaccines
- 17.3.3.3.1 United Kingdom Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.4 Inactivated Vaccines
- 17.3.3.4.1 United Kingdom Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.5 Toxoid Vaccines
- 17.3.3.5.1 United Kingdom Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.3.3.1 Recombinant Vaccines
- 17.3.4 United Kingdom Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.3.4.1 Pediatric Vaccine
- 17.3.4.1.1 United Kingdom Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.2 Adult Vaccine
- 17.3.4.2.1 United Kingdom Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.3.4.1 Pediatric Vaccine
- 17.3.5 United Kingdom Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.3.5.1 Pneumococcal Disease
- 17.3.5.1.1 United Kingdom Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.2 Measles
- 17.3.5.2.1 United Kingdom Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.3 Mumps
- 17.3.5.3.1 United Kingdom Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.4 Varicella
- 17.3.5.4.1 United Kingdom Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.5 DPT
- 17.3.5.5.1 United Kingdom DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.6 Hepatitis
- 17.3.5.6.1 United Kingdom Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.7 Influenza
- 17.3.5.7.1 United Kingdom Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.8 Typhoid
- 17.3.5.8.1 United Kingdom Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.9 Meningococcal
- 17.3.5.9.1 United Kingdom Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.10 Rabies
- 17.3.5.10.1 United Kingdom Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.11 Japanese Encephalitis
- 17.3.5.11.1 United Kingdom Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.12 Yellow Fever
- 17.3.5.12.1 United Kingdom Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.13 Others
- 17.3.5.13.1 United Kingdom Others Market Share and Revenue (USD Million) for 2018-2030
- 17.3.5.1 Pneumococcal Disease
- 17.3.6 United Kingdom Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.3.6.1 Injectable
- 17.3.6.1.1 United Kingdom Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.3.6.2 Oral
- 17.3.6.2.1 United Kingdom Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.3.6.3 Nasal
- 17.3.6.3.1 United Kingdom Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.3.6.1 Injectable
- 17.3.1 United Kingdom Vaccines Market (USD Million) by Type (2018-2030)
- 17.4 France Vaccines Market Size (2018-2030)
- 17.4.1 France Vaccines Market (USD Million) by Type (2018-2030)
- 17.4.1.1 Combination Vaccines
- 17.4.1.1.1 France Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.2 Monovaccines
- 17.4.1.2.1 France Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.1.1 Combination Vaccines
- 17.4.2 France Vaccines Market (USD Million) by Application (2018-2030)
- 17.4.2.1 Community Hospitals
- 17.4.2.1.1 France Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.2 Hospitals
- 17.4.2.2.1 France Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.3 Specialty Centres
- 17.4.2.3.1 France Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.4 Clinics
- 17.4.2.4.1 France Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.5 Others
- 17.4.2.5.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.2.1 Community Hospitals
- 17.4.3 France Vaccines Market (USD Million) by Technology (2018-2030)
- 17.4.3.1 Recombinant Vaccines
- 17.4.3.1.1 France Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.2 Conjugate Vaccines
- 17.4.3.2.1 France Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.3 Live-Attenuated Vaccines
- 17.4.3.3.1 France Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.4 Inactivated Vaccines
- 17.4.3.4.1 France Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.5 Toxoid Vaccines
- 17.4.3.5.1 France Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.4.3.1 Recombinant Vaccines
- 17.4.4 France Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.4.4.1 Pediatric Vaccine
- 17.4.4.1.1 France Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.2 Adult Vaccine
- 17.4.4.2.1 France Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.4.4.1 Pediatric Vaccine
- 17.4.5 France Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.4.5.1 Pneumococcal Disease
- 17.4.5.1.1 France Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.2 Measles
- 17.4.5.2.1 France Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.3 Mumps
- 17.4.5.3.1 France Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.4 Varicella
- 17.4.5.4.1 France Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.5 DPT
- 17.4.5.5.1 France DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.6 Hepatitis
- 17.4.5.6.1 France Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.7 Influenza
- 17.4.5.7.1 France Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.8 Typhoid
- 17.4.5.8.1 France Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.9 Meningococcal
- 17.4.5.9.1 France Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.10 Rabies
- 17.4.5.10.1 France Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.11 Japanese Encephalitis
- 17.4.5.11.1 France Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.12 Yellow Fever
- 17.4.5.12.1 France Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.13 Others
- 17.4.5.13.1 France Others Market Share and Revenue (USD Million) for 2018-2030
- 17.4.5.1 Pneumococcal Disease
- 17.4.6 France Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.4.6.1 Injectable
- 17.4.6.1.1 France Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.4.6.2 Oral
- 17.4.6.2.1 France Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.4.6.3 Nasal
- 17.4.6.3.1 France Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.4.6.1 Injectable
- 17.4.1 France Vaccines Market (USD Million) by Type (2018-2030)
- 17.5 Germany Vaccines Market Size (2018-2030)
- 17.5.1 Germany Vaccines Market (USD Million) by Type (2018-2030)
- 17.5.1.1 Combination Vaccines
- 17.5.1.1.1 Germany Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.2 Monovaccines
- 17.5.1.2.1 Germany Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.1.1 Combination Vaccines
- 17.5.2 Germany Vaccines Market (USD Million) by Application (2018-2030)
- 17.5.2.1 Community Hospitals
- 17.5.2.1.1 Germany Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.2 Hospitals
- 17.5.2.2.1 Germany Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.3 Specialty Centres
- 17.5.2.3.1 Germany Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.4 Clinics
- 17.5.2.4.1 Germany Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.5 Others
- 17.5.2.5.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.2.1 Community Hospitals
- 17.5.3 Germany Vaccines Market (USD Million) by Technology (2018-2030)
- 17.5.3.1 Recombinant Vaccines
- 17.5.3.1.1 Germany Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.2 Conjugate Vaccines
- 17.5.3.2.1 Germany Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.3 Live-Attenuated Vaccines
- 17.5.3.3.1 Germany Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.4 Inactivated Vaccines
- 17.5.3.4.1 Germany Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.5 Toxoid Vaccines
- 17.5.3.5.1 Germany Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.5.3.1 Recombinant Vaccines
- 17.5.4 Germany Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.5.4.1 Pediatric Vaccine
- 17.5.4.1.1 Germany Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.2 Adult Vaccine
- 17.5.4.2.1 Germany Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.5.4.1 Pediatric Vaccine
- 17.5.5 Germany Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.5.5.1 Pneumococcal Disease
- 17.5.5.1.1 Germany Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.2 Measles
- 17.5.5.2.1 Germany Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.3 Mumps
- 17.5.5.3.1 Germany Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.4 Varicella
- 17.5.5.4.1 Germany Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.5 DPT
- 17.5.5.5.1 Germany DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.6 Hepatitis
- 17.5.5.6.1 Germany Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.7 Influenza
- 17.5.5.7.1 Germany Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.8 Typhoid
- 17.5.5.8.1 Germany Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.9 Meningococcal
- 17.5.5.9.1 Germany Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.10 Rabies
- 17.5.5.10.1 Germany Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.11 Japanese Encephalitis
- 17.5.5.11.1 Germany Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.12 Yellow Fever
- 17.5.5.12.1 Germany Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.13 Others
- 17.5.5.13.1 Germany Others Market Share and Revenue (USD Million) for 2018-2030
- 17.5.5.1 Pneumococcal Disease
- 17.5.6 Germany Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.5.6.1 Injectable
- 17.5.6.1.1 Germany Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.5.6.2 Oral
- 17.5.6.2.1 Germany Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.5.6.3 Nasal
- 17.5.6.3.1 Germany Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.5.6.1 Injectable
- 17.5.1 Germany Vaccines Market (USD Million) by Type (2018-2030)
- 17.6 Italy Vaccines Market Size (2018-2030)
- 17.6.1 Italy Vaccines Market (USD Million) by Type (2018-2030)
- 17.6.1.1 Combination Vaccines
- 17.6.1.1.1 Italy Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.2 Monovaccines
- 17.6.1.2.1 Italy Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.1.1 Combination Vaccines
- 17.6.2 Italy Vaccines Market (USD Million) by Application (2018-2030)
- 17.6.2.1 Community Hospitals
- 17.6.2.1.1 Italy Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.2 Hospitals
- 17.6.2.2.1 Italy Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.3 Specialty Centres
- 17.6.2.3.1 Italy Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.4 Clinics
- 17.6.2.4.1 Italy Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.5 Others
- 17.6.2.5.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.2.1 Community Hospitals
- 17.6.3 Italy Vaccines Market (USD Million) by Technology (2018-2030)
- 17.6.3.1 Recombinant Vaccines
- 17.6.3.1.1 Italy Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.2 Conjugate Vaccines
- 17.6.3.2.1 Italy Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.3 Live-Attenuated Vaccines
- 17.6.3.3.1 Italy Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.4 Inactivated Vaccines
- 17.6.3.4.1 Italy Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.5 Toxoid Vaccines
- 17.6.3.5.1 Italy Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.6.3.1 Recombinant Vaccines
- 17.6.4 Italy Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.6.4.1 Pediatric Vaccine
- 17.6.4.1.1 Italy Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.2 Adult Vaccine
- 17.6.4.2.1 Italy Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.6.4.1 Pediatric Vaccine
- 17.6.5 Italy Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.6.5.1 Pneumococcal Disease
- 17.6.5.1.1 Italy Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.2 Measles
- 17.6.5.2.1 Italy Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.3 Mumps
- 17.6.5.3.1 Italy Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.4 Varicella
- 17.6.5.4.1 Italy Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.5 DPT
- 17.6.5.5.1 Italy DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.6 Hepatitis
- 17.6.5.6.1 Italy Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.7 Influenza
- 17.6.5.7.1 Italy Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.8 Typhoid
- 17.6.5.8.1 Italy Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.9 Meningococcal
- 17.6.5.9.1 Italy Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.10 Rabies
- 17.6.5.10.1 Italy Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.11 Japanese Encephalitis
- 17.6.5.11.1 Italy Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.12 Yellow Fever
- 17.6.5.12.1 Italy Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.13 Others
- 17.6.5.13.1 Italy Others Market Share and Revenue (USD Million) for 2018-2030
- 17.6.5.1 Pneumococcal Disease
- 17.6.6 Italy Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.6.6.1 Injectable
- 17.6.6.1.1 Italy Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.6.6.2 Oral
- 17.6.6.2.1 Italy Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.6.6.3 Nasal
- 17.6.6.3.1 Italy Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.6.6.1 Injectable
- 17.6.1 Italy Vaccines Market (USD Million) by Type (2018-2030)
- 17.7 Russia Vaccines Market Size (2018-2030)
- 17.7.1 Russia Vaccines Market (USD Million) by Type (2018-2030)
- 17.7.1.1 Combination Vaccines
- 17.7.1.1.1 Russia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.2 Monovaccines
- 17.7.1.2.1 Russia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.1.1 Combination Vaccines
- 17.7.2 Russia Vaccines Market (USD Million) by Application (2018-2030)
- 17.7.2.1 Community Hospitals
- 17.7.2.1.1 Russia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.2 Hospitals
- 17.7.2.2.1 Russia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.3 Specialty Centres
- 17.7.2.3.1 Russia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.4 Clinics
- 17.7.2.4.1 Russia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.5 Others
- 17.7.2.5.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.2.1 Community Hospitals
- 17.7.3 Russia Vaccines Market (USD Million) by Technology (2018-2030)
- 17.7.3.1 Recombinant Vaccines
- 17.7.3.1.1 Russia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.2 Conjugate Vaccines
- 17.7.3.2.1 Russia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.3 Live-Attenuated Vaccines
- 17.7.3.3.1 Russia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.4 Inactivated Vaccines
- 17.7.3.4.1 Russia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.5 Toxoid Vaccines
- 17.7.3.5.1 Russia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.7.3.1 Recombinant Vaccines
- 17.7.4 Russia Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.7.4.1 Pediatric Vaccine
- 17.7.4.1.1 Russia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.2 Adult Vaccine
- 17.7.4.2.1 Russia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.7.4.1 Pediatric Vaccine
- 17.7.5 Russia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.7.5.1 Pneumococcal Disease
- 17.7.5.1.1 Russia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.2 Measles
- 17.7.5.2.1 Russia Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.3 Mumps
- 17.7.5.3.1 Russia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.4 Varicella
- 17.7.5.4.1 Russia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.5 DPT
- 17.7.5.5.1 Russia DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.6 Hepatitis
- 17.7.5.6.1 Russia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.7 Influenza
- 17.7.5.7.1 Russia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.8 Typhoid
- 17.7.5.8.1 Russia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.9 Meningococcal
- 17.7.5.9.1 Russia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.10 Rabies
- 17.7.5.10.1 Russia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.11 Japanese Encephalitis
- 17.7.5.11.1 Russia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.12 Yellow Fever
- 17.7.5.12.1 Russia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.13 Others
- 17.7.5.13.1 Russia Others Market Share and Revenue (USD Million) for 2018-2030
- 17.7.5.1 Pneumococcal Disease
- 17.7.6 Russia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.7.6.1 Injectable
- 17.7.6.1.1 Russia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.7.6.2 Oral
- 17.7.6.2.1 Russia Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.7.6.3 Nasal
- 17.7.6.3.1 Russia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.7.6.1 Injectable
- 17.7.1 Russia Vaccines Market (USD Million) by Type (2018-2030)
- 17.8 Spain Vaccines Market Size (2018-2030)
- 17.8.1 Spain Vaccines Market (USD Million) by Type (2018-2030)
- 17.8.1.1 Combination Vaccines
- 17.8.1.1.1 Spain Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.2 Monovaccines
- 17.8.1.2.1 Spain Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.1.1 Combination Vaccines
- 17.8.2 Spain Vaccines Market (USD Million) by Application (2018-2030)
- 17.8.2.1 Community Hospitals
- 17.8.2.1.1 Spain Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.2 Hospitals
- 17.8.2.2.1 Spain Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.3 Specialty Centres
- 17.8.2.3.1 Spain Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.4 Clinics
- 17.8.2.4.1 Spain Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.5 Others
- 17.8.2.5.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.2.1 Community Hospitals
- 17.8.3 Spain Vaccines Market (USD Million) by Technology (2018-2030)
- 17.8.3.1 Recombinant Vaccines
- 17.8.3.1.1 Spain Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.2 Conjugate Vaccines
- 17.8.3.2.1 Spain Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.3 Live-Attenuated Vaccines
- 17.8.3.3.1 Spain Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.4 Inactivated Vaccines
- 17.8.3.4.1 Spain Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.5 Toxoid Vaccines
- 17.8.3.5.1 Spain Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.8.3.1 Recombinant Vaccines
- 17.8.4 Spain Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.8.4.1 Pediatric Vaccine
- 17.8.4.1.1 Spain Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.2 Adult Vaccine
- 17.8.4.2.1 Spain Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.8.4.1 Pediatric Vaccine
- 17.8.5 Spain Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.8.5.1 Pneumococcal Disease
- 17.8.5.1.1 Spain Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.2 Measles
- 17.8.5.2.1 Spain Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.3 Mumps
- 17.8.5.3.1 Spain Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.4 Varicella
- 17.8.5.4.1 Spain Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.5 DPT
- 17.8.5.5.1 Spain DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.6 Hepatitis
- 17.8.5.6.1 Spain Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.7 Influenza
- 17.8.5.7.1 Spain Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.8 Typhoid
- 17.8.5.8.1 Spain Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.9 Meningococcal
- 17.8.5.9.1 Spain Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.10 Rabies
- 17.8.5.10.1 Spain Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.11 Japanese Encephalitis
- 17.8.5.11.1 Spain Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.12 Yellow Fever
- 17.8.5.12.1 Spain Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.13 Others
- 17.8.5.13.1 Spain Others Market Share and Revenue (USD Million) for 2018-2030
- 17.8.5.1 Pneumococcal Disease
- 17.8.6 Spain Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.8.6.1 Injectable
- 17.8.6.1.1 Spain Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.8.6.2 Oral
- 17.8.6.2.1 Spain Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.8.6.3 Nasal
- 17.8.6.3.1 Spain Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.8.6.1 Injectable
- 17.8.1 Spain Vaccines Market (USD Million) by Type (2018-2030)
- 17.9 Sweden Vaccines Market Size (2018-2030)
- 17.9.1 Sweden Vaccines Market (USD Million) by Type (2018-2030)
- 17.9.1.1 Combination Vaccines
- 17.9.1.1.1 Sweden Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.2 Monovaccines
- 17.9.1.2.1 Sweden Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.1.1 Combination Vaccines
- 17.9.2 Sweden Vaccines Market (USD Million) by Application (2018-2030)
- 17.9.2.1 Community Hospitals
- 17.9.2.1.1 Sweden Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.2 Hospitals
- 17.9.2.2.1 Sweden Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.3 Specialty Centres
- 17.9.2.3.1 Sweden Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.4 Clinics
- 17.9.2.4.1 Sweden Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.5 Others
- 17.9.2.5.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 17.9.2.1 Community Hospitals
- 17.9.3 Sweden Vaccines Market (USD Million) by Technology (2018-2030)
- 17.9.3.1 Recombinant Vaccines
- 17.9.3.1.1 Sweden Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.2 Conjugate Vaccines
- 17.9.3.2.1 Sweden Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.3 Live-Attenuated Vaccines
- 17.9.3.3.1 Sweden Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.4 Inactivated Vaccines
- 17.9.3.4.1 Sweden Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.5 Toxoid Vaccines
- 17.9.3.5.1 Sweden Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.9.3.1 Recombinant Vaccines
- 17.9.4 Sweden Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.9.4.1 Pediatric Vaccine
- 17.9.4.1.1 Sweden Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.9.4.2 Adult Vaccine
- 17.9.4.2.1 Sweden Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.9.4.1 Pediatric Vaccine
- 17.9.5 Sweden Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.9.5.1 Pneumococcal Disease
- 17.9.5.1.1 Sweden Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.2 Measles
- 17.9.5.2.1 Sweden Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.3 Mumps
- 17.9.5.3.1 Sweden Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.4 Varicella
- 17.9.5.4.1 Sweden Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.5 DPT
- 17.9.5.5.1 Sweden DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.6 Hepatitis
- 17.9.5.6.1 Sweden Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.7 Influenza
- 17.9.5.7.1 Sweden Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.8 Typhoid
- 17.9.5.8.1 Sweden Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.9 Meningococcal
- 17.9.5.9.1 Sweden Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.10 Rabies
- 17.9.5.10.1 Sweden Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.11 Japanese Encephalitis
- 17.9.5.11.1 Sweden Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.12 Yellow Fever
- 17.9.5.12.1 Sweden Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.13 Others
- 17.9.5.13.1 Sweden Others Market Share and Revenue (USD Million) for 2018-2030
- 17.9.5.1 Pneumococcal Disease
- 17.9.6 Sweden Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.9.6.1 Injectable
- 17.9.6.1.1 Sweden Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.9.6.2 Oral
- 17.9.6.2.1 Sweden Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.9.6.3 Nasal
- 17.9.6.3.1 Sweden Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.9.6.1 Injectable
- 17.9.1 Sweden Vaccines Market (USD Million) by Type (2018-2030)
- 17.10 Denmark Vaccines Market Size (2018-2030)
- 17.10.1 Denmark Vaccines Market (USD Million) by Type (2018-2030)
- 17.10.1.1 Combination Vaccines
- 17.10.1.1.1 Denmark Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.2 Monovaccines
- 17.10.1.2.1 Denmark Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.1.1 Combination Vaccines
- 17.10.2 Denmark Vaccines Market (USD Million) by Application (2018-2030)
- 17.10.2.1 Community Hospitals
- 17.10.2.1.1 Denmark Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.2 Hospitals
- 17.10.2.2.1 Denmark Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.3 Specialty Centres
- 17.10.2.3.1 Denmark Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.4 Clinics
- 17.10.2.4.1 Denmark Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.5 Others
- 17.10.2.5.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 17.10.2.1 Community Hospitals
- 17.10.3 Denmark Vaccines Market (USD Million) by Technology (2018-2030)
- 17.10.3.1 Recombinant Vaccines
- 17.10.3.1.1 Denmark Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.2 Conjugate Vaccines
- 17.10.3.2.1 Denmark Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.3 Live-Attenuated Vaccines
- 17.10.3.3.1 Denmark Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.4 Inactivated Vaccines
- 17.10.3.4.1 Denmark Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.5 Toxoid Vaccines
- 17.10.3.5.1 Denmark Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.10.3.1 Recombinant Vaccines
- 17.10.4 Denmark Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.10.4.1 Pediatric Vaccine
- 17.10.4.1.1 Denmark Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.10.4.2 Adult Vaccine
- 17.10.4.2.1 Denmark Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.10.4.1 Pediatric Vaccine
- 17.10.5 Denmark Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.10.5.1 Pneumococcal Disease
- 17.10.5.1.1 Denmark Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.2 Measles
- 17.10.5.2.1 Denmark Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.3 Mumps
- 17.10.5.3.1 Denmark Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.4 Varicella
- 17.10.5.4.1 Denmark Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.5 DPT
- 17.10.5.5.1 Denmark DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.6 Hepatitis
- 17.10.5.6.1 Denmark Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.7 Influenza
- 17.10.5.7.1 Denmark Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.8 Typhoid
- 17.10.5.8.1 Denmark Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.9 Meningococcal
- 17.10.5.9.1 Denmark Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.10 Rabies
- 17.10.5.10.1 Denmark Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.11 Japanese Encephalitis
- 17.10.5.11.1 Denmark Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.12 Yellow Fever
- 17.10.5.12.1 Denmark Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.13 Others
- 17.10.5.13.1 Denmark Others Market Share and Revenue (USD Million) for 2018-2030
- 17.10.5.1 Pneumococcal Disease
- 17.10.6 Denmark Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.10.6.1 Injectable
- 17.10.6.1.1 Denmark Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.10.6.2 Oral
- 17.10.6.2.1 Denmark Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.10.6.3 Nasal
- 17.10.6.3.1 Denmark Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.10.6.1 Injectable
- 17.10.1 Denmark Vaccines Market (USD Million) by Type (2018-2030)
- 17.11 Netherlands Vaccines Market Size (2018-2030)
- 17.11.1 Netherlands Vaccines Market (USD Million) by Type (2018-2030)
- 17.11.1.1 Combination Vaccines
- 17.11.1.1.1 Netherlands Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.2 Monovaccines
- 17.11.1.2.1 Netherlands Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.1.1 Combination Vaccines
- 17.11.2 Netherlands Vaccines Market (USD Million) by Application (2018-2030)
- 17.11.2.1 Community Hospitals
- 17.11.2.1.1 Netherlands Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.2 Hospitals
- 17.11.2.2.1 Netherlands Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.3 Specialty Centres
- 17.11.2.3.1 Netherlands Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.4 Clinics
- 17.11.2.4.1 Netherlands Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.5 Others
- 17.11.2.5.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 17.11.2.1 Community Hospitals
- 17.11.3 Netherlands Vaccines Market (USD Million) by Technology (2018-2030)
- 17.11.3.1 Recombinant Vaccines
- 17.11.3.1.1 Netherlands Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.2 Conjugate Vaccines
- 17.11.3.2.1 Netherlands Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.3 Live-Attenuated Vaccines
- 17.11.3.3.1 Netherlands Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.4 Inactivated Vaccines
- 17.11.3.4.1 Netherlands Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.5 Toxoid Vaccines
- 17.11.3.5.1 Netherlands Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.11.3.1 Recombinant Vaccines
- 17.11.4 Netherlands Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.11.4.1 Pediatric Vaccine
- 17.11.4.1.1 Netherlands Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.11.4.2 Adult Vaccine
- 17.11.4.2.1 Netherlands Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.11.4.1 Pediatric Vaccine
- 17.11.5 Netherlands Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.11.5.1 Pneumococcal Disease
- 17.11.5.1.1 Netherlands Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.2 Measles
- 17.11.5.2.1 Netherlands Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.3 Mumps
- 17.11.5.3.1 Netherlands Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.4 Varicella
- 17.11.5.4.1 Netherlands Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.5 DPT
- 17.11.5.5.1 Netherlands DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.6 Hepatitis
- 17.11.5.6.1 Netherlands Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.7 Influenza
- 17.11.5.7.1 Netherlands Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.8 Typhoid
- 17.11.5.8.1 Netherlands Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.9 Meningococcal
- 17.11.5.9.1 Netherlands Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.10 Rabies
- 17.11.5.10.1 Netherlands Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.11 Japanese Encephalitis
- 17.11.5.11.1 Netherlands Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.12 Yellow Fever
- 17.11.5.12.1 Netherlands Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.13 Others
- 17.11.5.13.1 Netherlands Others Market Share and Revenue (USD Million) for 2018-2030
- 17.11.5.1 Pneumococcal Disease
- 17.11.6 Netherlands Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.11.6.1 Injectable
- 17.11.6.1.1 Netherlands Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.11.6.2 Oral
- 17.11.6.2.1 Netherlands Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.11.6.3 Nasal
- 17.11.6.3.1 Netherlands Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.11.6.1 Injectable
- 17.11.1 Netherlands Vaccines Market (USD Million) by Type (2018-2030)
- 17.12 Switzerland Vaccines Market Size (2018-2030)
- 17.12.1 Switzerland Vaccines Market (USD Million) by Type (2018-2030)
- 17.12.1.1 Combination Vaccines
- 17.12.1.1.1 Switzerland Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.2 Monovaccines
- 17.12.1.2.1 Switzerland Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.1.1 Combination Vaccines
- 17.12.2 Switzerland Vaccines Market (USD Million) by Application (2018-2030)
- 17.12.2.1 Community Hospitals
- 17.12.2.1.1 Switzerland Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.2 Hospitals
- 17.12.2.2.1 Switzerland Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.3 Specialty Centres
- 17.12.2.3.1 Switzerland Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.4 Clinics
- 17.12.2.4.1 Switzerland Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.5 Others
- 17.12.2.5.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 17.12.2.1 Community Hospitals
- 17.12.3 Switzerland Vaccines Market (USD Million) by Technology (2018-2030)
- 17.12.3.1 Recombinant Vaccines
- 17.12.3.1.1 Switzerland Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.2 Conjugate Vaccines
- 17.12.3.2.1 Switzerland Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.3 Live-Attenuated Vaccines
- 17.12.3.3.1 Switzerland Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.4 Inactivated Vaccines
- 17.12.3.4.1 Switzerland Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.5 Toxoid Vaccines
- 17.12.3.5.1 Switzerland Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.12.3.1 Recombinant Vaccines
- 17.12.4 Switzerland Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.12.4.1 Pediatric Vaccine
- 17.12.4.1.1 Switzerland Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.12.4.2 Adult Vaccine
- 17.12.4.2.1 Switzerland Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.12.4.1 Pediatric Vaccine
- 17.12.5 Switzerland Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.12.5.1 Pneumococcal Disease
- 17.12.5.1.1 Switzerland Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.2 Measles
- 17.12.5.2.1 Switzerland Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.3 Mumps
- 17.12.5.3.1 Switzerland Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.4 Varicella
- 17.12.5.4.1 Switzerland Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.5 DPT
- 17.12.5.5.1 Switzerland DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.6 Hepatitis
- 17.12.5.6.1 Switzerland Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.7 Influenza
- 17.12.5.7.1 Switzerland Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.8 Typhoid
- 17.12.5.8.1 Switzerland Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.9 Meningococcal
- 17.12.5.9.1 Switzerland Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.10 Rabies
- 17.12.5.10.1 Switzerland Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.11 Japanese Encephalitis
- 17.12.5.11.1 Switzerland Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.12 Yellow Fever
- 17.12.5.12.1 Switzerland Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.13 Others
- 17.12.5.13.1 Switzerland Others Market Share and Revenue (USD Million) for 2018-2030
- 17.12.5.1 Pneumococcal Disease
- 17.12.6 Switzerland Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.12.6.1 Injectable
- 17.12.6.1.1 Switzerland Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.12.6.2 Oral
- 17.12.6.2.1 Switzerland Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.12.6.3 Nasal
- 17.12.6.3.1 Switzerland Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.12.6.1 Injectable
- 17.12.1 Switzerland Vaccines Market (USD Million) by Type (2018-2030)
- 17.13 Belgium Vaccines Market Size (2018-2030)
- 17.13.1 Belgium Vaccines Market (USD Million) by Type (2018-2030)
- 17.13.1.1 Combination Vaccines
- 17.13.1.1.1 Belgium Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.2 Monovaccines
- 17.13.1.2.1 Belgium Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.1.1 Combination Vaccines
- 17.13.2 Belgium Vaccines Market (USD Million) by Application (2018-2030)
- 17.13.2.1 Community Hospitals
- 17.13.2.1.1 Belgium Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.2 Hospitals
- 17.13.2.2.1 Belgium Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.3 Specialty Centres
- 17.13.2.3.1 Belgium Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.4 Clinics
- 17.13.2.4.1 Belgium Clinics Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.5 Others
- 17.13.2.5.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 17.13.2.1 Community Hospitals
- 17.13.3 Belgium Vaccines Market (USD Million) by Technology (2018-2030)
- 17.13.3.1 Recombinant Vaccines
- 17.13.3.1.1 Belgium Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.2 Conjugate Vaccines
- 17.13.3.2.1 Belgium Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.3 Live-Attenuated Vaccines
- 17.13.3.3.1 Belgium Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.4 Inactivated Vaccines
- 17.13.3.4.1 Belgium Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.5 Toxoid Vaccines
- 17.13.3.5.1 Belgium Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 17.13.3.1 Recombinant Vaccines
- 17.13.4 Belgium Vaccines Market (USD Million) by Age Group (2018-2030)
- 17.13.4.1 Pediatric Vaccine
- 17.13.4.1.1 Belgium Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.13.4.2 Adult Vaccine
- 17.13.4.2.1 Belgium Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 17.13.4.1 Pediatric Vaccine
- 17.13.5 Belgium Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 17.13.5.1 Pneumococcal Disease
- 17.13.5.1.1 Belgium Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.2 Measles
- 17.13.5.2.1 Belgium Measles Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.3 Mumps
- 17.13.5.3.1 Belgium Mumps Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.4 Varicella
- 17.13.5.4.1 Belgium Varicella Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.5 DPT
- 17.13.5.5.1 Belgium DPT Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.6 Hepatitis
- 17.13.5.6.1 Belgium Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.7 Influenza
- 17.13.5.7.1 Belgium Influenza Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.8 Typhoid
- 17.13.5.8.1 Belgium Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.9 Meningococcal
- 17.13.5.9.1 Belgium Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.10 Rabies
- 17.13.5.10.1 Belgium Rabies Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.11 Japanese Encephalitis
- 17.13.5.11.1 Belgium Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.12 Yellow Fever
- 17.13.5.12.1 Belgium Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.13 Others
- 17.13.5.13.1 Belgium Others Market Share and Revenue (USD Million) for 2018-2030
- 17.13.5.1 Pneumococcal Disease
- 17.13.6 Belgium Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 17.13.6.1 Injectable
- 17.13.6.1.1 Belgium Injectable Market Share and Revenue (USD Million) for 2018-2030
- 17.13.6.2 Oral
- 17.13.6.2.1 Belgium Oral Market Share and Revenue (USD Million) for 2018-2030
- 17.13.6.3 Nasal
- 17.13.6.3.1 Belgium Nasal Market Share and Revenue (USD Million) for 2018-2030
- 17.13.6.1 Injectable
- 17.13.1 Belgium Vaccines Market (USD Million) by Type (2018-2030)
- 18.1 Asia Pacific
- 18.1.1 Asia Pacific Vaccines Market Trends and Analysis
- 18.1.2 Asia Pacific Vaccines Market by Country, 2018-2030
- 18.1.3 Asia Pacific Vaccines Market Attractiveness Analysis by Country
- 18.2 Asia Pacific Vaccines Market Size (2018-2030)
- 18.2.1 Asia Pacific Vaccines Market (USD Million) by Type (2018-2030)
- 18.2.1.1 Combination Vaccines
- 18.2.1.1.1 Asia Pacific Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.2 Monovaccines
- 18.2.1.2.1 Asia Pacific Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.1.1 Combination Vaccines
- 18.2.2 Asia Pacific Vaccines Market (USD Million) by Application (2018-2030)
- 18.2.2.1 Community Hospitals
- 18.2.2.1.1 Asia Pacific Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.2 Hospitals
- 18.2.2.2.1 Asia Pacific Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.3 Specialty Centres
- 18.2.2.3.1 Asia Pacific Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.4 Clinics
- 18.2.2.4.1 Asia Pacific Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.5 Others
- 18.2.2.5.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.2.1 Community Hospitals
- 18.2.3 Asia Pacific Vaccines Market (USD Million) by Technology (2018-2030)
- 18.2.3.1 Recombinant Vaccines
- 18.2.3.1.1 Asia Pacific Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.2 Conjugate Vaccines
- 18.2.3.2.1 Asia Pacific Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.3 Live-Attenuated Vaccines
- 18.2.3.3.1 Asia Pacific Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.4 Inactivated Vaccines
- 18.2.3.4.1 Asia Pacific Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.5 Toxoid Vaccines
- 18.2.3.5.1 Asia Pacific Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.2.3.1 Recombinant Vaccines
- 18.2.4 Asia Pacific Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.2.4.1 Pediatric Vaccine
- 18.2.4.1.1 Asia Pacific Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.2 Adult Vaccine
- 18.2.4.2.1 Asia Pacific Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.2.4.1 Pediatric Vaccine
- 18.2.5 Asia Pacific Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.2.5.1 Pneumococcal Disease
- 18.2.5.1.1 Asia Pacific Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.2 Measles
- 18.2.5.2.1 Asia Pacific Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.3 Mumps
- 18.2.5.3.1 Asia Pacific Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.4 Varicella
- 18.2.5.4.1 Asia Pacific Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.5 DPT
- 18.2.5.5.1 Asia Pacific DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.6 Hepatitis
- 18.2.5.6.1 Asia Pacific Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.7 Influenza
- 18.2.5.7.1 Asia Pacific Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.8 Typhoid
- 18.2.5.8.1 Asia Pacific Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.9 Meningococcal
- 18.2.5.9.1 Asia Pacific Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.10 Rabies
- 18.2.5.10.1 Asia Pacific Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.11 Japanese Encephalitis
- 18.2.5.11.1 Asia Pacific Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.12 Yellow Fever
- 18.2.5.12.1 Asia Pacific Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.13 Others
- 18.2.5.13.1 Asia Pacific Others Market Share and Revenue (USD Million) for 2018-2030
- 18.2.5.1 Pneumococcal Disease
- 18.2.6 Asia Pacific Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.2.6.1 Injectable
- 18.2.6.1.1 Asia Pacific Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.2.6.2 Oral
- 18.2.6.2.1 Asia Pacific Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.2.6.3 Nasal
- 18.2.6.3.1 Asia Pacific Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.2.6.1 Injectable
- 18.2.1 Asia Pacific Vaccines Market (USD Million) by Type (2018-2030)
- 18.3 China Vaccines Market Size (2018-2030)
- 18.3.1 China Vaccines Market (USD Million) by Type (2018-2030)
- 18.3.1.1 Combination Vaccines
- 18.3.1.1.1 China Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.2 Monovaccines
- 18.3.1.2.1 China Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.1.1 Combination Vaccines
- 18.3.2 China Vaccines Market (USD Million) by Application (2018-2030)
- 18.3.2.1 Community Hospitals
- 18.3.2.1.1 China Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.2 Hospitals
- 18.3.2.2.1 China Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.3 Specialty Centres
- 18.3.2.3.1 China Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.4 Clinics
- 18.3.2.4.1 China Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.5 Others
- 18.3.2.5.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.2.1 Community Hospitals
- 18.3.3 China Vaccines Market (USD Million) by Technology (2018-2030)
- 18.3.3.1 Recombinant Vaccines
- 18.3.3.1.1 China Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.2 Conjugate Vaccines
- 18.3.3.2.1 China Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.3 Live-Attenuated Vaccines
- 18.3.3.3.1 China Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.4 Inactivated Vaccines
- 18.3.3.4.1 China Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.5 Toxoid Vaccines
- 18.3.3.5.1 China Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.3.3.1 Recombinant Vaccines
- 18.3.4 China Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.3.4.1 Pediatric Vaccine
- 18.3.4.1.1 China Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.2 Adult Vaccine
- 18.3.4.2.1 China Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.3.4.1 Pediatric Vaccine
- 18.3.5 China Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.3.5.1 Pneumococcal Disease
- 18.3.5.1.1 China Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.2 Measles
- 18.3.5.2.1 China Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.3 Mumps
- 18.3.5.3.1 China Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.4 Varicella
- 18.3.5.4.1 China Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.5 DPT
- 18.3.5.5.1 China DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.6 Hepatitis
- 18.3.5.6.1 China Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.7 Influenza
- 18.3.5.7.1 China Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.8 Typhoid
- 18.3.5.8.1 China Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.9 Meningococcal
- 18.3.5.9.1 China Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.10 Rabies
- 18.3.5.10.1 China Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.11 Japanese Encephalitis
- 18.3.5.11.1 China Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.12 Yellow Fever
- 18.3.5.12.1 China Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.13 Others
- 18.3.5.13.1 China Others Market Share and Revenue (USD Million) for 2018-2030
- 18.3.5.1 Pneumococcal Disease
- 18.3.6 China Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.3.6.1 Injectable
- 18.3.6.1.1 China Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.3.6.2 Oral
- 18.3.6.2.1 China Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.3.6.3 Nasal
- 18.3.6.3.1 China Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.3.6.1 Injectable
- 18.3.1 China Vaccines Market (USD Million) by Type (2018-2030)
- 18.4 Japan Vaccines Market Size (2018-2030)
- 18.4.1 Japan Vaccines Market (USD Million) by Type (2018-2030)
- 18.4.1.1 Combination Vaccines
- 18.4.1.1.1 Japan Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.2 Monovaccines
- 18.4.1.2.1 Japan Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.1.1 Combination Vaccines
- 18.4.2 Japan Vaccines Market (USD Million) by Application (2018-2030)
- 18.4.2.1 Community Hospitals
- 18.4.2.1.1 Japan Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.2 Hospitals
- 18.4.2.2.1 Japan Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.3 Specialty Centres
- 18.4.2.3.1 Japan Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.4 Clinics
- 18.4.2.4.1 Japan Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.5 Others
- 18.4.2.5.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.2.1 Community Hospitals
- 18.4.3 Japan Vaccines Market (USD Million) by Technology (2018-2030)
- 18.4.3.1 Recombinant Vaccines
- 18.4.3.1.1 Japan Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.2 Conjugate Vaccines
- 18.4.3.2.1 Japan Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.3 Live-Attenuated Vaccines
- 18.4.3.3.1 Japan Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.4 Inactivated Vaccines
- 18.4.3.4.1 Japan Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.5 Toxoid Vaccines
- 18.4.3.5.1 Japan Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.4.3.1 Recombinant Vaccines
- 18.4.4 Japan Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.4.4.1 Pediatric Vaccine
- 18.4.4.1.1 Japan Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.2 Adult Vaccine
- 18.4.4.2.1 Japan Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.4.4.1 Pediatric Vaccine
- 18.4.5 Japan Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.4.5.1 Pneumococcal Disease
- 18.4.5.1.1 Japan Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.2 Measles
- 18.4.5.2.1 Japan Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.3 Mumps
- 18.4.5.3.1 Japan Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.4 Varicella
- 18.4.5.4.1 Japan Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.5 DPT
- 18.4.5.5.1 Japan DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.6 Hepatitis
- 18.4.5.6.1 Japan Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.7 Influenza
- 18.4.5.7.1 Japan Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.8 Typhoid
- 18.4.5.8.1 Japan Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.9 Meningococcal
- 18.4.5.9.1 Japan Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.10 Rabies
- 18.4.5.10.1 Japan Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.11 Japanese Encephalitis
- 18.4.5.11.1 Japan Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.12 Yellow Fever
- 18.4.5.12.1 Japan Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.13 Others
- 18.4.5.13.1 Japan Others Market Share and Revenue (USD Million) for 2018-2030
- 18.4.5.1 Pneumococcal Disease
- 18.4.6 Japan Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.4.6.1 Injectable
- 18.4.6.1.1 Japan Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.4.6.2 Oral
- 18.4.6.2.1 Japan Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.4.6.3 Nasal
- 18.4.6.3.1 Japan Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.4.6.1 Injectable
- 18.4.1 Japan Vaccines Market (USD Million) by Type (2018-2030)
- 18.5 Korea Vaccines Market Size (2018-2030)
- 18.5.1 Korea Vaccines Market (USD Million) by Type (2018-2030)
- 18.5.1.1 Combination Vaccines
- 18.5.1.1.1 Korea Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.2 Monovaccines
- 18.5.1.2.1 Korea Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.1.1 Combination Vaccines
- 18.5.2 Korea Vaccines Market (USD Million) by Application (2018-2030)
- 18.5.2.1 Community Hospitals
- 18.5.2.1.1 Korea Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.2 Hospitals
- 18.5.2.2.1 Korea Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.3 Specialty Centres
- 18.5.2.3.1 Korea Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.4 Clinics
- 18.5.2.4.1 Korea Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.5 Others
- 18.5.2.5.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.2.1 Community Hospitals
- 18.5.3 Korea Vaccines Market (USD Million) by Technology (2018-2030)
- 18.5.3.1 Recombinant Vaccines
- 18.5.3.1.1 Korea Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.2 Conjugate Vaccines
- 18.5.3.2.1 Korea Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.3 Live-Attenuated Vaccines
- 18.5.3.3.1 Korea Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.4 Inactivated Vaccines
- 18.5.3.4.1 Korea Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.5 Toxoid Vaccines
- 18.5.3.5.1 Korea Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.5.3.1 Recombinant Vaccines
- 18.5.4 Korea Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.5.4.1 Pediatric Vaccine
- 18.5.4.1.1 Korea Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.2 Adult Vaccine
- 18.5.4.2.1 Korea Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.5.4.1 Pediatric Vaccine
- 18.5.5 Korea Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.5.5.1 Pneumococcal Disease
- 18.5.5.1.1 Korea Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.2 Measles
- 18.5.5.2.1 Korea Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.3 Mumps
- 18.5.5.3.1 Korea Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.4 Varicella
- 18.5.5.4.1 Korea Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.5 DPT
- 18.5.5.5.1 Korea DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.6 Hepatitis
- 18.5.5.6.1 Korea Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.7 Influenza
- 18.5.5.7.1 Korea Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.8 Typhoid
- 18.5.5.8.1 Korea Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.9 Meningococcal
- 18.5.5.9.1 Korea Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.10 Rabies
- 18.5.5.10.1 Korea Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.11 Japanese Encephalitis
- 18.5.5.11.1 Korea Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.12 Yellow Fever
- 18.5.5.12.1 Korea Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.13 Others
- 18.5.5.13.1 Korea Others Market Share and Revenue (USD Million) for 2018-2030
- 18.5.5.1 Pneumococcal Disease
- 18.5.6 Korea Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.5.6.1 Injectable
- 18.5.6.1.1 Korea Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.5.6.2 Oral
- 18.5.6.2.1 Korea Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.5.6.3 Nasal
- 18.5.6.3.1 Korea Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.5.6.1 Injectable
- 18.5.1 Korea Vaccines Market (USD Million) by Type (2018-2030)
- 18.6 India Vaccines Market Size (2018-2030)
- 18.6.1 India Vaccines Market (USD Million) by Type (2018-2030)
- 18.6.1.1 Combination Vaccines
- 18.6.1.1.1 India Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.2 Monovaccines
- 18.6.1.2.1 India Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.1.1 Combination Vaccines
- 18.6.2 India Vaccines Market (USD Million) by Application (2018-2030)
- 18.6.2.1 Community Hospitals
- 18.6.2.1.1 India Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.2 Hospitals
- 18.6.2.2.1 India Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.3 Specialty Centres
- 18.6.2.3.1 India Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.4 Clinics
- 18.6.2.4.1 India Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.5 Others
- 18.6.2.5.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.2.1 Community Hospitals
- 18.6.3 India Vaccines Market (USD Million) by Technology (2018-2030)
- 18.6.3.1 Recombinant Vaccines
- 18.6.3.1.1 India Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.2 Conjugate Vaccines
- 18.6.3.2.1 India Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.3 Live-Attenuated Vaccines
- 18.6.3.3.1 India Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.4 Inactivated Vaccines
- 18.6.3.4.1 India Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.5 Toxoid Vaccines
- 18.6.3.5.1 India Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.6.3.1 Recombinant Vaccines
- 18.6.4 India Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.6.4.1 Pediatric Vaccine
- 18.6.4.1.1 India Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.2 Adult Vaccine
- 18.6.4.2.1 India Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.6.4.1 Pediatric Vaccine
- 18.6.5 India Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.6.5.1 Pneumococcal Disease
- 18.6.5.1.1 India Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.2 Measles
- 18.6.5.2.1 India Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.3 Mumps
- 18.6.5.3.1 India Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.4 Varicella
- 18.6.5.4.1 India Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.5 DPT
- 18.6.5.5.1 India DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.6 Hepatitis
- 18.6.5.6.1 India Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.7 Influenza
- 18.6.5.7.1 India Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.8 Typhoid
- 18.6.5.8.1 India Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.9 Meningococcal
- 18.6.5.9.1 India Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.10 Rabies
- 18.6.5.10.1 India Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.11 Japanese Encephalitis
- 18.6.5.11.1 India Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.12 Yellow Fever
- 18.6.5.12.1 India Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.13 Others
- 18.6.5.13.1 India Others Market Share and Revenue (USD Million) for 2018-2030
- 18.6.5.1 Pneumococcal Disease
- 18.6.6 India Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.6.6.1 Injectable
- 18.6.6.1.1 India Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.6.6.2 Oral
- 18.6.6.2.1 India Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.6.6.3 Nasal
- 18.6.6.3.1 India Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.6.6.1 Injectable
- 18.6.1 India Vaccines Market (USD Million) by Type (2018-2030)
- 18.7 Australia Vaccines Market Size (2018-2030)
- 18.7.1 Australia Vaccines Market (USD Million) by Type (2018-2030)
- 18.7.1.1 Combination Vaccines
- 18.7.1.1.1 Australia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.2 Monovaccines
- 18.7.1.2.1 Australia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.1.1 Combination Vaccines
- 18.7.2 Australia Vaccines Market (USD Million) by Application (2018-2030)
- 18.7.2.1 Community Hospitals
- 18.7.2.1.1 Australia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.2 Hospitals
- 18.7.2.2.1 Australia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.3 Specialty Centres
- 18.7.2.3.1 Australia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.4 Clinics
- 18.7.2.4.1 Australia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.5 Others
- 18.7.2.5.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.2.1 Community Hospitals
- 18.7.3 Australia Vaccines Market (USD Million) by Technology (2018-2030)
- 18.7.3.1 Recombinant Vaccines
- 18.7.3.1.1 Australia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.2 Conjugate Vaccines
- 18.7.3.2.1 Australia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.3 Live-Attenuated Vaccines
- 18.7.3.3.1 Australia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.4 Inactivated Vaccines
- 18.7.3.4.1 Australia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.5 Toxoid Vaccines
- 18.7.3.5.1 Australia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.7.3.1 Recombinant Vaccines
- 18.7.4 Australia Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.7.4.1 Pediatric Vaccine
- 18.7.4.1.1 Australia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.2 Adult Vaccine
- 18.7.4.2.1 Australia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.7.4.1 Pediatric Vaccine
- 18.7.5 Australia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.7.5.1 Pneumococcal Disease
- 18.7.5.1.1 Australia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.2 Measles
- 18.7.5.2.1 Australia Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.3 Mumps
- 18.7.5.3.1 Australia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.4 Varicella
- 18.7.5.4.1 Australia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.5 DPT
- 18.7.5.5.1 Australia DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.6 Hepatitis
- 18.7.5.6.1 Australia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.7 Influenza
- 18.7.5.7.1 Australia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.8 Typhoid
- 18.7.5.8.1 Australia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.9 Meningococcal
- 18.7.5.9.1 Australia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.10 Rabies
- 18.7.5.10.1 Australia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.11 Japanese Encephalitis
- 18.7.5.11.1 Australia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.12 Yellow Fever
- 18.7.5.12.1 Australia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.13 Others
- 18.7.5.13.1 Australia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.7.5.1 Pneumococcal Disease
- 18.7.6 Australia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.7.6.1 Injectable
- 18.7.6.1.1 Australia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.7.6.2 Oral
- 18.7.6.2.1 Australia Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.7.6.3 Nasal
- 18.7.6.3.1 Australia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.7.6.1 Injectable
- 18.7.1 Australia Vaccines Market (USD Million) by Type (2018-2030)
- 18.8 Philippines Vaccines Market Size (2018-2030)
- 18.8.1 Philippines Vaccines Market (USD Million) by Type (2018-2030)
- 18.8.1.1 Combination Vaccines
- 18.8.1.1.1 Philippines Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.2 Monovaccines
- 18.8.1.2.1 Philippines Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.1.1 Combination Vaccines
- 18.8.2 Philippines Vaccines Market (USD Million) by Application (2018-2030)
- 18.8.2.1 Community Hospitals
- 18.8.2.1.1 Philippines Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.2 Hospitals
- 18.8.2.2.1 Philippines Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.3 Specialty Centres
- 18.8.2.3.1 Philippines Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.4 Clinics
- 18.8.2.4.1 Philippines Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.5 Others
- 18.8.2.5.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.2.1 Community Hospitals
- 18.8.3 Philippines Vaccines Market (USD Million) by Technology (2018-2030)
- 18.8.3.1 Recombinant Vaccines
- 18.8.3.1.1 Philippines Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.2 Conjugate Vaccines
- 18.8.3.2.1 Philippines Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.3 Live-Attenuated Vaccines
- 18.8.3.3.1 Philippines Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.4 Inactivated Vaccines
- 18.8.3.4.1 Philippines Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.5 Toxoid Vaccines
- 18.8.3.5.1 Philippines Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.8.3.1 Recombinant Vaccines
- 18.8.4 Philippines Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.8.4.1 Pediatric Vaccine
- 18.8.4.1.1 Philippines Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.2 Adult Vaccine
- 18.8.4.2.1 Philippines Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.8.4.1 Pediatric Vaccine
- 18.8.5 Philippines Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.8.5.1 Pneumococcal Disease
- 18.8.5.1.1 Philippines Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.2 Measles
- 18.8.5.2.1 Philippines Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.3 Mumps
- 18.8.5.3.1 Philippines Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.4 Varicella
- 18.8.5.4.1 Philippines Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.5 DPT
- 18.8.5.5.1 Philippines DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.6 Hepatitis
- 18.8.5.6.1 Philippines Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.7 Influenza
- 18.8.5.7.1 Philippines Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.8 Typhoid
- 18.8.5.8.1 Philippines Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.9 Meningococcal
- 18.8.5.9.1 Philippines Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.10 Rabies
- 18.8.5.10.1 Philippines Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.11 Japanese Encephalitis
- 18.8.5.11.1 Philippines Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.12 Yellow Fever
- 18.8.5.12.1 Philippines Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.13 Others
- 18.8.5.13.1 Philippines Others Market Share and Revenue (USD Million) for 2018-2030
- 18.8.5.1 Pneumococcal Disease
- 18.8.6 Philippines Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.8.6.1 Injectable
- 18.8.6.1.1 Philippines Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.8.6.2 Oral
- 18.8.6.2.1 Philippines Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.8.6.3 Nasal
- 18.8.6.3.1 Philippines Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.8.6.1 Injectable
- 18.8.1 Philippines Vaccines Market (USD Million) by Type (2018-2030)
- 18.9 Singapore Vaccines Market Size (2018-2030)
- 18.9.1 Singapore Vaccines Market (USD Million) by Type (2018-2030)
- 18.9.1.1 Combination Vaccines
- 18.9.1.1.1 Singapore Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.2 Monovaccines
- 18.9.1.2.1 Singapore Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.1.1 Combination Vaccines
- 18.9.2 Singapore Vaccines Market (USD Million) by Application (2018-2030)
- 18.9.2.1 Community Hospitals
- 18.9.2.1.1 Singapore Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.2 Hospitals
- 18.9.2.2.1 Singapore Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.3 Specialty Centres
- 18.9.2.3.1 Singapore Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.4 Clinics
- 18.9.2.4.1 Singapore Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.5 Others
- 18.9.2.5.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 18.9.2.1 Community Hospitals
- 18.9.3 Singapore Vaccines Market (USD Million) by Technology (2018-2030)
- 18.9.3.1 Recombinant Vaccines
- 18.9.3.1.1 Singapore Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.2 Conjugate Vaccines
- 18.9.3.2.1 Singapore Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.3 Live-Attenuated Vaccines
- 18.9.3.3.1 Singapore Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.4 Inactivated Vaccines
- 18.9.3.4.1 Singapore Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.5 Toxoid Vaccines
- 18.9.3.5.1 Singapore Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.9.3.1 Recombinant Vaccines
- 18.9.4 Singapore Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.9.4.1 Pediatric Vaccine
- 18.9.4.1.1 Singapore Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.9.4.2 Adult Vaccine
- 18.9.4.2.1 Singapore Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.9.4.1 Pediatric Vaccine
- 18.9.5 Singapore Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.9.5.1 Pneumococcal Disease
- 18.9.5.1.1 Singapore Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.2 Measles
- 18.9.5.2.1 Singapore Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.3 Mumps
- 18.9.5.3.1 Singapore Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.4 Varicella
- 18.9.5.4.1 Singapore Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.5 DPT
- 18.9.5.5.1 Singapore DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.6 Hepatitis
- 18.9.5.6.1 Singapore Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.7 Influenza
- 18.9.5.7.1 Singapore Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.8 Typhoid
- 18.9.5.8.1 Singapore Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.9 Meningococcal
- 18.9.5.9.1 Singapore Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.10 Rabies
- 18.9.5.10.1 Singapore Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.11 Japanese Encephalitis
- 18.9.5.11.1 Singapore Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.12 Yellow Fever
- 18.9.5.12.1 Singapore Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.13 Others
- 18.9.5.13.1 Singapore Others Market Share and Revenue (USD Million) for 2018-2030
- 18.9.5.1 Pneumococcal Disease
- 18.9.6 Singapore Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.9.6.1 Injectable
- 18.9.6.1.1 Singapore Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.9.6.2 Oral
- 18.9.6.2.1 Singapore Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.9.6.3 Nasal
- 18.9.6.3.1 Singapore Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.9.6.1 Injectable
- 18.9.1 Singapore Vaccines Market (USD Million) by Type (2018-2030)
- 18.10 Malaysia Vaccines Market Size (2018-2030)
- 18.10.1 Malaysia Vaccines Market (USD Million) by Type (2018-2030)
- 18.10.1.1 Combination Vaccines
- 18.10.1.1.1 Malaysia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.2 Monovaccines
- 18.10.1.2.1 Malaysia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.1.1 Combination Vaccines
- 18.10.2 Malaysia Vaccines Market (USD Million) by Application (2018-2030)
- 18.10.2.1 Community Hospitals
- 18.10.2.1.1 Malaysia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.2 Hospitals
- 18.10.2.2.1 Malaysia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.3 Specialty Centres
- 18.10.2.3.1 Malaysia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.4 Clinics
- 18.10.2.4.1 Malaysia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.5 Others
- 18.10.2.5.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.10.2.1 Community Hospitals
- 18.10.3 Malaysia Vaccines Market (USD Million) by Technology (2018-2030)
- 18.10.3.1 Recombinant Vaccines
- 18.10.3.1.1 Malaysia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.2 Conjugate Vaccines
- 18.10.3.2.1 Malaysia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.3 Live-Attenuated Vaccines
- 18.10.3.3.1 Malaysia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.4 Inactivated Vaccines
- 18.10.3.4.1 Malaysia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.5 Toxoid Vaccines
- 18.10.3.5.1 Malaysia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.10.3.1 Recombinant Vaccines
- 18.10.4 Malaysia Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.10.4.1 Pediatric Vaccine
- 18.10.4.1.1 Malaysia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.10.4.2 Adult Vaccine
- 18.10.4.2.1 Malaysia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.10.4.1 Pediatric Vaccine
- 18.10.5 Malaysia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.10.5.1 Pneumococcal Disease
- 18.10.5.1.1 Malaysia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.2 Measles
- 18.10.5.2.1 Malaysia Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.3 Mumps
- 18.10.5.3.1 Malaysia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.4 Varicella
- 18.10.5.4.1 Malaysia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.5 DPT
- 18.10.5.5.1 Malaysia DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.6 Hepatitis
- 18.10.5.6.1 Malaysia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.7 Influenza
- 18.10.5.7.1 Malaysia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.8 Typhoid
- 18.10.5.8.1 Malaysia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.9 Meningococcal
- 18.10.5.9.1 Malaysia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.10 Rabies
- 18.10.5.10.1 Malaysia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.11 Japanese Encephalitis
- 18.10.5.11.1 Malaysia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.12 Yellow Fever
- 18.10.5.12.1 Malaysia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.13 Others
- 18.10.5.13.1 Malaysia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.10.5.1 Pneumococcal Disease
- 18.10.6 Malaysia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.10.6.1 Injectable
- 18.10.6.1.1 Malaysia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.10.6.2 Oral
- 18.10.6.2.1 Malaysia Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.10.6.3 Nasal
- 18.10.6.3.1 Malaysia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.10.6.1 Injectable
- 18.10.1 Malaysia Vaccines Market (USD Million) by Type (2018-2030)
- 18.11 Thailand Vaccines Market Size (2018-2030)
- 18.11.1 Thailand Vaccines Market (USD Million) by Type (2018-2030)
- 18.11.1.1 Combination Vaccines
- 18.11.1.1.1 Thailand Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.1.2 Monovaccines
- 18.11.1.2.1 Thailand Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.1.1 Combination Vaccines
- 18.11.2 Thailand Vaccines Market (USD Million) by Application (2018-2030)
- 18.11.2.1 Community Hospitals
- 18.11.2.1.1 Thailand Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.11.2.2 Hospitals
- 18.11.2.2.1 Thailand Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.11.2.3 Specialty Centres
- 18.11.2.3.1 Thailand Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.11.2.4 Clinics
- 18.11.2.4.1 Thailand Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.11.2.5 Others
- 18.11.2.5.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 18.11.2.1 Community Hospitals
- 18.11.3 Thailand Vaccines Market (USD Million) by Technology (2018-2030)
- 18.11.3.1 Recombinant Vaccines
- 18.11.3.1.1 Thailand Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.3.2 Conjugate Vaccines
- 18.11.3.2.1 Thailand Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.3.3 Live-Attenuated Vaccines
- 18.11.3.3.1 Thailand Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.3.4 Inactivated Vaccines
- 18.11.3.4.1 Thailand Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.3.5 Toxoid Vaccines
- 18.11.3.5.1 Thailand Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.11.3.1 Recombinant Vaccines
- 18.11.4 Thailand Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.11.4.1 Pediatric Vaccine
- 18.11.4.1.1 Thailand Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.11.4.2 Adult Vaccine
- 18.11.4.2.1 Thailand Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.11.4.1 Pediatric Vaccine
- 18.11.5 Thailand Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.11.5.1 Pneumococcal Disease
- 18.11.5.1.1 Thailand Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.2 Measles
- 18.11.5.2.1 Thailand Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.3 Mumps
- 18.11.5.3.1 Thailand Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.4 Varicella
- 18.11.5.4.1 Thailand Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.5 DPT
- 18.11.5.5.1 Thailand DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.6 Hepatitis
- 18.11.5.6.1 Thailand Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.7 Influenza
- 18.11.5.7.1 Thailand Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.8 Typhoid
- 18.11.5.8.1 Thailand Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.9 Meningococcal
- 18.11.5.9.1 Thailand Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.10 Rabies
- 18.11.5.10.1 Thailand Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.11 Japanese Encephalitis
- 18.11.5.11.1 Thailand Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.12 Yellow Fever
- 18.11.5.12.1 Thailand Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.13 Others
- 18.11.5.13.1 Thailand Others Market Share and Revenue (USD Million) for 2018-2030
- 18.11.5.1 Pneumococcal Disease
- 18.11.6 Thailand Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.11.6.1 Injectable
- 18.11.6.1.1 Thailand Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.11.6.2 Oral
- 18.11.6.2.1 Thailand Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.11.6.3 Nasal
- 18.11.6.3.1 Thailand Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.11.6.1 Injectable
- 18.11.1 Thailand Vaccines Market (USD Million) by Type (2018-2030)
- 18.12 Indonesia Vaccines Market Size (2018-2030)
- 18.12.1 Indonesia Vaccines Market (USD Million) by Type (2018-2030)
- 18.12.1.1 Combination Vaccines
- 18.12.1.1.1 Indonesia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.1.2 Monovaccines
- 18.12.1.2.1 Indonesia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.1.1 Combination Vaccines
- 18.12.2 Indonesia Vaccines Market (USD Million) by Application (2018-2030)
- 18.12.2.1 Community Hospitals
- 18.12.2.1.1 Indonesia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.12.2.2 Hospitals
- 18.12.2.2.1 Indonesia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.12.2.3 Specialty Centres
- 18.12.2.3.1 Indonesia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.12.2.4 Clinics
- 18.12.2.4.1 Indonesia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.12.2.5 Others
- 18.12.2.5.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.12.2.1 Community Hospitals
- 18.12.3 Indonesia Vaccines Market (USD Million) by Technology (2018-2030)
- 18.12.3.1 Recombinant Vaccines
- 18.12.3.1.1 Indonesia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.3.2 Conjugate Vaccines
- 18.12.3.2.1 Indonesia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.3.3 Live-Attenuated Vaccines
- 18.12.3.3.1 Indonesia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.3.4 Inactivated Vaccines
- 18.12.3.4.1 Indonesia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.3.5 Toxoid Vaccines
- 18.12.3.5.1 Indonesia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.12.3.1 Recombinant Vaccines
- 18.12.4 Indonesia Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.12.4.1 Pediatric Vaccine
- 18.12.4.1.1 Indonesia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.12.4.2 Adult Vaccine
- 18.12.4.2.1 Indonesia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.12.4.1 Pediatric Vaccine
- 18.12.5 Indonesia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.12.5.1 Pneumococcal Disease
- 18.12.5.1.1 Indonesia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.2 Measles
- 18.12.5.2.1 Indonesia Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.3 Mumps
- 18.12.5.3.1 Indonesia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.4 Varicella
- 18.12.5.4.1 Indonesia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.5 DPT
- 18.12.5.5.1 Indonesia DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.6 Hepatitis
- 18.12.5.6.1 Indonesia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.7 Influenza
- 18.12.5.7.1 Indonesia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.8 Typhoid
- 18.12.5.8.1 Indonesia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.9 Meningococcal
- 18.12.5.9.1 Indonesia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.10 Rabies
- 18.12.5.10.1 Indonesia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.11 Japanese Encephalitis
- 18.12.5.11.1 Indonesia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.12 Yellow Fever
- 18.12.5.12.1 Indonesia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.13 Others
- 18.12.5.13.1 Indonesia Others Market Share and Revenue (USD Million) for 2018-2030
- 18.12.5.1 Pneumococcal Disease
- 18.12.6 Indonesia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.12.6.1 Injectable
- 18.12.6.1.1 Indonesia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.12.6.2 Oral
- 18.12.6.2.1 Indonesia Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.12.6.3 Nasal
- 18.12.6.3.1 Indonesia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.12.6.1 Injectable
- 18.12.1 Indonesia Vaccines Market (USD Million) by Type (2018-2030)
- 18.13 Rest of APAC Vaccines Market Size (2018-2030)
- 18.13.1 Rest of APAC Vaccines Market (USD Million) by Type (2018-2030)
- 18.13.1.1 Combination Vaccines
- 18.13.1.1.1 Rest of APAC Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.1.2 Monovaccines
- 18.13.1.2.1 Rest of APAC Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.1.1 Combination Vaccines
- 18.13.2 Rest of APAC Vaccines Market (USD Million) by Application (2018-2030)
- 18.13.2.1 Community Hospitals
- 18.13.2.1.1 Rest of APAC Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.13.2.2 Hospitals
- 18.13.2.2.1 Rest of APAC Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 18.13.2.3 Specialty Centres
- 18.13.2.3.1 Rest of APAC Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 18.13.2.4 Clinics
- 18.13.2.4.1 Rest of APAC Clinics Market Share and Revenue (USD Million) for 2018-2030
- 18.13.2.5 Others
- 18.13.2.5.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 18.13.2.1 Community Hospitals
- 18.13.3 Rest of APAC Vaccines Market (USD Million) by Technology (2018-2030)
- 18.13.3.1 Recombinant Vaccines
- 18.13.3.1.1 Rest of APAC Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.3.2 Conjugate Vaccines
- 18.13.3.2.1 Rest of APAC Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.3.3 Live-Attenuated Vaccines
- 18.13.3.3.1 Rest of APAC Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.3.4 Inactivated Vaccines
- 18.13.3.4.1 Rest of APAC Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.3.5 Toxoid Vaccines
- 18.13.3.5.1 Rest of APAC Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 18.13.3.1 Recombinant Vaccines
- 18.13.4 Rest of APAC Vaccines Market (USD Million) by Age Group (2018-2030)
- 18.13.4.1 Pediatric Vaccine
- 18.13.4.1.1 Rest of APAC Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.13.4.2 Adult Vaccine
- 18.13.4.2.1 Rest of APAC Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 18.13.4.1 Pediatric Vaccine
- 18.13.5 Rest of APAC Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 18.13.5.1 Pneumococcal Disease
- 18.13.5.1.1 Rest of APAC Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.2 Measles
- 18.13.5.2.1 Rest of APAC Measles Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.3 Mumps
- 18.13.5.3.1 Rest of APAC Mumps Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.4 Varicella
- 18.13.5.4.1 Rest of APAC Varicella Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.5 DPT
- 18.13.5.5.1 Rest of APAC DPT Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.6 Hepatitis
- 18.13.5.6.1 Rest of APAC Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.7 Influenza
- 18.13.5.7.1 Rest of APAC Influenza Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.8 Typhoid
- 18.13.5.8.1 Rest of APAC Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.9 Meningococcal
- 18.13.5.9.1 Rest of APAC Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.10 Rabies
- 18.13.5.10.1 Rest of APAC Rabies Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.11 Japanese Encephalitis
- 18.13.5.11.1 Rest of APAC Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.12 Yellow Fever
- 18.13.5.12.1 Rest of APAC Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.13 Others
- 18.13.5.13.1 Rest of APAC Others Market Share and Revenue (USD Million) for 2018-2030
- 18.13.5.1 Pneumococcal Disease
- 18.13.6 Rest of APAC Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 18.13.6.1 Injectable
- 18.13.6.1.1 Rest of APAC Injectable Market Share and Revenue (USD Million) for 2018-2030
- 18.13.6.2 Oral
- 18.13.6.2.1 Rest of APAC Oral Market Share and Revenue (USD Million) for 2018-2030
- 18.13.6.3 Nasal
- 18.13.6.3.1 Rest of APAC Nasal Market Share and Revenue (USD Million) for 2018-2030
- 18.13.6.1 Injectable
- 18.13.1 Rest of APAC Vaccines Market (USD Million) by Type (2018-2030)
- 19.1 Latin America
- 19.1.1 Latin America Vaccines Market Trends and Analysis
- 19.1.2 Latin America Vaccines Market by Country, 2018-2030
- 19.1.3 Latin America Vaccines Market Attractiveness Analysis by Country
- 19.2 Latin America Vaccines Market Size (2018-2030)
- 19.2.1 Latin America Vaccines Market (USD Million) by Type (2018-2030)
- 19.2.1.1 Combination Vaccines
- 19.2.1.1.1 Latin America Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.2 Monovaccines
- 19.2.1.2.1 Latin America Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.1.1 Combination Vaccines
- 19.2.2 Latin America Vaccines Market (USD Million) by Application (2018-2030)
- 19.2.2.1 Community Hospitals
- 19.2.2.1.1 Latin America Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.2 Hospitals
- 19.2.2.2.1 Latin America Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.3 Specialty Centres
- 19.2.2.3.1 Latin America Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.4 Clinics
- 19.2.2.4.1 Latin America Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.5 Others
- 19.2.2.5.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 19.2.2.1 Community Hospitals
- 19.2.3 Latin America Vaccines Market (USD Million) by Technology (2018-2030)
- 19.2.3.1 Recombinant Vaccines
- 19.2.3.1.1 Latin America Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.2 Conjugate Vaccines
- 19.2.3.2.1 Latin America Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.3 Live-Attenuated Vaccines
- 19.2.3.3.1 Latin America Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.4 Inactivated Vaccines
- 19.2.3.4.1 Latin America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.5 Toxoid Vaccines
- 19.2.3.5.1 Latin America Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.2.3.1 Recombinant Vaccines
- 19.2.4 Latin America Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.2.4.1 Pediatric Vaccine
- 19.2.4.1.1 Latin America Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.2.4.2 Adult Vaccine
- 19.2.4.2.1 Latin America Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.2.4.1 Pediatric Vaccine
- 19.2.5 Latin America Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.2.5.1 Pneumococcal Disease
- 19.2.5.1.1 Latin America Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.2 Measles
- 19.2.5.2.1 Latin America Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.3 Mumps
- 19.2.5.3.1 Latin America Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.4 Varicella
- 19.2.5.4.1 Latin America Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.5 DPT
- 19.2.5.5.1 Latin America DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.6 Hepatitis
- 19.2.5.6.1 Latin America Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.7 Influenza
- 19.2.5.7.1 Latin America Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.8 Typhoid
- 19.2.5.8.1 Latin America Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.9 Meningococcal
- 19.2.5.9.1 Latin America Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.10 Rabies
- 19.2.5.10.1 Latin America Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.11 Japanese Encephalitis
- 19.2.5.11.1 Latin America Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.12 Yellow Fever
- 19.2.5.12.1 Latin America Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.13 Others
- 19.2.5.13.1 Latin America Others Market Share and Revenue (USD Million) for 2018-2030
- 19.2.5.1 Pneumococcal Disease
- 19.2.6 Latin America Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.2.6.1 Injectable
- 19.2.6.1.1 Latin America Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.2.6.2 Oral
- 19.2.6.2.1 Latin America Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.2.6.3 Nasal
- 19.2.6.3.1 Latin America Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.2.6.1 Injectable
- 19.2.1 Latin America Vaccines Market (USD Million) by Type (2018-2030)
- 19.3 Brazil Vaccines Market Size (2018-2030)
- 19.3.1 Brazil Vaccines Market (USD Million) by Type (2018-2030)
- 19.3.1.1 Combination Vaccines
- 19.3.1.1.1 Brazil Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.2 Monovaccines
- 19.3.1.2.1 Brazil Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.1.1 Combination Vaccines
- 19.3.2 Brazil Vaccines Market (USD Million) by Application (2018-2030)
- 19.3.2.1 Community Hospitals
- 19.3.2.1.1 Brazil Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.2 Hospitals
- 19.3.2.2.1 Brazil Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.3 Specialty Centres
- 19.3.2.3.1 Brazil Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.4 Clinics
- 19.3.2.4.1 Brazil Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.5 Others
- 19.3.2.5.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 19.3.2.1 Community Hospitals
- 19.3.3 Brazil Vaccines Market (USD Million) by Technology (2018-2030)
- 19.3.3.1 Recombinant Vaccines
- 19.3.3.1.1 Brazil Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.2 Conjugate Vaccines
- 19.3.3.2.1 Brazil Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.3 Live-Attenuated Vaccines
- 19.3.3.3.1 Brazil Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.4 Inactivated Vaccines
- 19.3.3.4.1 Brazil Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.5 Toxoid Vaccines
- 19.3.3.5.1 Brazil Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.3.3.1 Recombinant Vaccines
- 19.3.4 Brazil Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.3.4.1 Pediatric Vaccine
- 19.3.4.1.1 Brazil Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.3.4.2 Adult Vaccine
- 19.3.4.2.1 Brazil Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.3.4.1 Pediatric Vaccine
- 19.3.5 Brazil Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.3.5.1 Pneumococcal Disease
- 19.3.5.1.1 Brazil Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.2 Measles
- 19.3.5.2.1 Brazil Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.3 Mumps
- 19.3.5.3.1 Brazil Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.4 Varicella
- 19.3.5.4.1 Brazil Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.5 DPT
- 19.3.5.5.1 Brazil DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.6 Hepatitis
- 19.3.5.6.1 Brazil Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.7 Influenza
- 19.3.5.7.1 Brazil Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.8 Typhoid
- 19.3.5.8.1 Brazil Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.9 Meningococcal
- 19.3.5.9.1 Brazil Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.10 Rabies
- 19.3.5.10.1 Brazil Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.11 Japanese Encephalitis
- 19.3.5.11.1 Brazil Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.12 Yellow Fever
- 19.3.5.12.1 Brazil Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.13 Others
- 19.3.5.13.1 Brazil Others Market Share and Revenue (USD Million) for 2018-2030
- 19.3.5.1 Pneumococcal Disease
- 19.3.6 Brazil Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.3.6.1 Injectable
- 19.3.6.1.1 Brazil Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.3.6.2 Oral
- 19.3.6.2.1 Brazil Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.3.6.3 Nasal
- 19.3.6.3.1 Brazil Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.3.6.1 Injectable
- 19.3.1 Brazil Vaccines Market (USD Million) by Type (2018-2030)
- 19.4 Argentina Vaccines Market Size (2018-2030)
- 19.4.1 Argentina Vaccines Market (USD Million) by Type (2018-2030)
- 19.4.1.1 Combination Vaccines
- 19.4.1.1.1 Argentina Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.2 Monovaccines
- 19.4.1.2.1 Argentina Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.1.1 Combination Vaccines
- 19.4.2 Argentina Vaccines Market (USD Million) by Application (2018-2030)
- 19.4.2.1 Community Hospitals
- 19.4.2.1.1 Argentina Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.2 Hospitals
- 19.4.2.2.1 Argentina Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.3 Specialty Centres
- 19.4.2.3.1 Argentina Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.4 Clinics
- 19.4.2.4.1 Argentina Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.5 Others
- 19.4.2.5.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 19.4.2.1 Community Hospitals
- 19.4.3 Argentina Vaccines Market (USD Million) by Technology (2018-2030)
- 19.4.3.1 Recombinant Vaccines
- 19.4.3.1.1 Argentina Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.2 Conjugate Vaccines
- 19.4.3.2.1 Argentina Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.3 Live-Attenuated Vaccines
- 19.4.3.3.1 Argentina Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.4 Inactivated Vaccines
- 19.4.3.4.1 Argentina Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.5 Toxoid Vaccines
- 19.4.3.5.1 Argentina Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.4.3.1 Recombinant Vaccines
- 19.4.4 Argentina Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.4.4.1 Pediatric Vaccine
- 19.4.4.1.1 Argentina Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.4.4.2 Adult Vaccine
- 19.4.4.2.1 Argentina Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.4.4.1 Pediatric Vaccine
- 19.4.5 Argentina Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.4.5.1 Pneumococcal Disease
- 19.4.5.1.1 Argentina Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.2 Measles
- 19.4.5.2.1 Argentina Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.3 Mumps
- 19.4.5.3.1 Argentina Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.4 Varicella
- 19.4.5.4.1 Argentina Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.5 DPT
- 19.4.5.5.1 Argentina DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.6 Hepatitis
- 19.4.5.6.1 Argentina Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.7 Influenza
- 19.4.5.7.1 Argentina Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.8 Typhoid
- 19.4.5.8.1 Argentina Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.9 Meningococcal
- 19.4.5.9.1 Argentina Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.10 Rabies
- 19.4.5.10.1 Argentina Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.11 Japanese Encephalitis
- 19.4.5.11.1 Argentina Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.12 Yellow Fever
- 19.4.5.12.1 Argentina Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.13 Others
- 19.4.5.13.1 Argentina Others Market Share and Revenue (USD Million) for 2018-2030
- 19.4.5.1 Pneumococcal Disease
- 19.4.6 Argentina Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.4.6.1 Injectable
- 19.4.6.1.1 Argentina Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.4.6.2 Oral
- 19.4.6.2.1 Argentina Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.4.6.3 Nasal
- 19.4.6.3.1 Argentina Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.4.6.1 Injectable
- 19.4.1 Argentina Vaccines Market (USD Million) by Type (2018-2030)
- 19.5 Colombia Vaccines Market Size (2018-2030)
- 19.5.1 Colombia Vaccines Market (USD Million) by Type (2018-2030)
- 19.5.1.1 Combination Vaccines
- 19.5.1.1.1 Colombia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.2 Monovaccines
- 19.5.1.2.1 Colombia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.1.1 Combination Vaccines
- 19.5.2 Colombia Vaccines Market (USD Million) by Application (2018-2030)
- 19.5.2.1 Community Hospitals
- 19.5.2.1.1 Colombia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.2 Hospitals
- 19.5.2.2.1 Colombia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.3 Specialty Centres
- 19.5.2.3.1 Colombia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.4 Clinics
- 19.5.2.4.1 Colombia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.5 Others
- 19.5.2.5.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 19.5.2.1 Community Hospitals
- 19.5.3 Colombia Vaccines Market (USD Million) by Technology (2018-2030)
- 19.5.3.1 Recombinant Vaccines
- 19.5.3.1.1 Colombia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.2 Conjugate Vaccines
- 19.5.3.2.1 Colombia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.3 Live-Attenuated Vaccines
- 19.5.3.3.1 Colombia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.4 Inactivated Vaccines
- 19.5.3.4.1 Colombia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.5 Toxoid Vaccines
- 19.5.3.5.1 Colombia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.5.3.1 Recombinant Vaccines
- 19.5.4 Colombia Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.5.4.1 Pediatric Vaccine
- 19.5.4.1.1 Colombia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.5.4.2 Adult Vaccine
- 19.5.4.2.1 Colombia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.5.4.1 Pediatric Vaccine
- 19.5.5 Colombia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.5.5.1 Pneumococcal Disease
- 19.5.5.1.1 Colombia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.2 Measles
- 19.5.5.2.1 Colombia Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.3 Mumps
- 19.5.5.3.1 Colombia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.4 Varicella
- 19.5.5.4.1 Colombia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.5 DPT
- 19.5.5.5.1 Colombia DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.6 Hepatitis
- 19.5.5.6.1 Colombia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.7 Influenza
- 19.5.5.7.1 Colombia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.8 Typhoid
- 19.5.5.8.1 Colombia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.9 Meningococcal
- 19.5.5.9.1 Colombia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.10 Rabies
- 19.5.5.10.1 Colombia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.11 Japanese Encephalitis
- 19.5.5.11.1 Colombia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.12 Yellow Fever
- 19.5.5.12.1 Colombia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.13 Others
- 19.5.5.13.1 Colombia Others Market Share and Revenue (USD Million) for 2018-2030
- 19.5.5.1 Pneumococcal Disease
- 19.5.6 Colombia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.5.6.1 Injectable
- 19.5.6.1.1 Colombia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.5.6.2 Oral
- 19.5.6.2.1 Colombia Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.5.6.3 Nasal
- 19.5.6.3.1 Colombia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.5.6.1 Injectable
- 19.5.1 Colombia Vaccines Market (USD Million) by Type (2018-2030)
- 19.6 Peru Vaccines Market Size (2018-2030)
- 19.6.1 Peru Vaccines Market (USD Million) by Type (2018-2030)
- 19.6.1.1 Combination Vaccines
- 19.6.1.1.1 Peru Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.2 Monovaccines
- 19.6.1.2.1 Peru Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.1.1 Combination Vaccines
- 19.6.2 Peru Vaccines Market (USD Million) by Application (2018-2030)
- 19.6.2.1 Community Hospitals
- 19.6.2.1.1 Peru Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.2 Hospitals
- 19.6.2.2.1 Peru Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.3 Specialty Centres
- 19.6.2.3.1 Peru Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.4 Clinics
- 19.6.2.4.1 Peru Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.5 Others
- 19.6.2.5.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 19.6.2.1 Community Hospitals
- 19.6.3 Peru Vaccines Market (USD Million) by Technology (2018-2030)
- 19.6.3.1 Recombinant Vaccines
- 19.6.3.1.1 Peru Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.2 Conjugate Vaccines
- 19.6.3.2.1 Peru Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.3 Live-Attenuated Vaccines
- 19.6.3.3.1 Peru Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.4 Inactivated Vaccines
- 19.6.3.4.1 Peru Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.5 Toxoid Vaccines
- 19.6.3.5.1 Peru Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.6.3.1 Recombinant Vaccines
- 19.6.4 Peru Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.6.4.1 Pediatric Vaccine
- 19.6.4.1.1 Peru Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.6.4.2 Adult Vaccine
- 19.6.4.2.1 Peru Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.6.4.1 Pediatric Vaccine
- 19.6.5 Peru Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.6.5.1 Pneumococcal Disease
- 19.6.5.1.1 Peru Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.2 Measles
- 19.6.5.2.1 Peru Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.3 Mumps
- 19.6.5.3.1 Peru Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.4 Varicella
- 19.6.5.4.1 Peru Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.5 DPT
- 19.6.5.5.1 Peru DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.6 Hepatitis
- 19.6.5.6.1 Peru Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.7 Influenza
- 19.6.5.7.1 Peru Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.8 Typhoid
- 19.6.5.8.1 Peru Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.9 Meningococcal
- 19.6.5.9.1 Peru Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.10 Rabies
- 19.6.5.10.1 Peru Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.11 Japanese Encephalitis
- 19.6.5.11.1 Peru Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.12 Yellow Fever
- 19.6.5.12.1 Peru Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.13 Others
- 19.6.5.13.1 Peru Others Market Share and Revenue (USD Million) for 2018-2030
- 19.6.5.1 Pneumococcal Disease
- 19.6.6 Peru Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.6.6.1 Injectable
- 19.6.6.1.1 Peru Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.6.6.2 Oral
- 19.6.6.2.1 Peru Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.6.6.3 Nasal
- 19.6.6.3.1 Peru Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.6.6.1 Injectable
- 19.6.1 Peru Vaccines Market (USD Million) by Type (2018-2030)
- 19.7 Chile Vaccines Market Size (2018-2030)
- 19.7.1 Chile Vaccines Market (USD Million) by Type (2018-2030)
- 19.7.1.1 Combination Vaccines
- 19.7.1.1.1 Chile Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.2 Monovaccines
- 19.7.1.2.1 Chile Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.1.1 Combination Vaccines
- 19.7.2 Chile Vaccines Market (USD Million) by Application (2018-2030)
- 19.7.2.1 Community Hospitals
- 19.7.2.1.1 Chile Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.2 Hospitals
- 19.7.2.2.1 Chile Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.3 Specialty Centres
- 19.7.2.3.1 Chile Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.4 Clinics
- 19.7.2.4.1 Chile Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.5 Others
- 19.7.2.5.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 19.7.2.1 Community Hospitals
- 19.7.3 Chile Vaccines Market (USD Million) by Technology (2018-2030)
- 19.7.3.1 Recombinant Vaccines
- 19.7.3.1.1 Chile Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.2 Conjugate Vaccines
- 19.7.3.2.1 Chile Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.3 Live-Attenuated Vaccines
- 19.7.3.3.1 Chile Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.4 Inactivated Vaccines
- 19.7.3.4.1 Chile Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.5 Toxoid Vaccines
- 19.7.3.5.1 Chile Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.7.3.1 Recombinant Vaccines
- 19.7.4 Chile Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.7.4.1 Pediatric Vaccine
- 19.7.4.1.1 Chile Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.7.4.2 Adult Vaccine
- 19.7.4.2.1 Chile Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.7.4.1 Pediatric Vaccine
- 19.7.5 Chile Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.7.5.1 Pneumococcal Disease
- 19.7.5.1.1 Chile Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.2 Measles
- 19.7.5.2.1 Chile Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.3 Mumps
- 19.7.5.3.1 Chile Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.4 Varicella
- 19.7.5.4.1 Chile Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.5 DPT
- 19.7.5.5.1 Chile DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.6 Hepatitis
- 19.7.5.6.1 Chile Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.7 Influenza
- 19.7.5.7.1 Chile Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.8 Typhoid
- 19.7.5.8.1 Chile Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.9 Meningococcal
- 19.7.5.9.1 Chile Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.10 Rabies
- 19.7.5.10.1 Chile Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.11 Japanese Encephalitis
- 19.7.5.11.1 Chile Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.12 Yellow Fever
- 19.7.5.12.1 Chile Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.13 Others
- 19.7.5.13.1 Chile Others Market Share and Revenue (USD Million) for 2018-2030
- 19.7.5.1 Pneumococcal Disease
- 19.7.6 Chile Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.7.6.1 Injectable
- 19.7.6.1.1 Chile Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.7.6.2 Oral
- 19.7.6.2.1 Chile Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.7.6.3 Nasal
- 19.7.6.3.1 Chile Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.7.6.1 Injectable
- 19.7.1 Chile Vaccines Market (USD Million) by Type (2018-2030)
- 19.8 Rest of South America Vaccines Market Size (2018-2030)
- 19.8.1 Rest of South America Vaccines Market (USD Million) by Type (2018-2030)
- 19.8.1.1 Combination Vaccines
- 19.8.1.1.1 Rest of South America Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.2 Monovaccines
- 19.8.1.2.1 Rest of South America Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.1.1 Combination Vaccines
- 19.8.2 Rest of South America Vaccines Market (USD Million) by Application (2018-2030)
- 19.8.2.1 Community Hospitals
- 19.8.2.1.1 Rest of South America Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.2 Hospitals
- 19.8.2.2.1 Rest of South America Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.3 Specialty Centres
- 19.8.2.3.1 Rest of South America Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.4 Clinics
- 19.8.2.4.1 Rest of South America Clinics Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.5 Others
- 19.8.2.5.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 19.8.2.1 Community Hospitals
- 19.8.3 Rest of South America Vaccines Market (USD Million) by Technology (2018-2030)
- 19.8.3.1 Recombinant Vaccines
- 19.8.3.1.1 Rest of South America Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.2 Conjugate Vaccines
- 19.8.3.2.1 Rest of South America Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.3 Live-Attenuated Vaccines
- 19.8.3.3.1 Rest of South America Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.4 Inactivated Vaccines
- 19.8.3.4.1 Rest of South America Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.5 Toxoid Vaccines
- 19.8.3.5.1 Rest of South America Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 19.8.3.1 Recombinant Vaccines
- 19.8.4 Rest of South America Vaccines Market (USD Million) by Age Group (2018-2030)
- 19.8.4.1 Pediatric Vaccine
- 19.8.4.1.1 Rest of South America Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.8.4.2 Adult Vaccine
- 19.8.4.2.1 Rest of South America Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 19.8.4.1 Pediatric Vaccine
- 19.8.5 Rest of South America Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 19.8.5.1 Pneumococcal Disease
- 19.8.5.1.1 Rest of South America Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.2 Measles
- 19.8.5.2.1 Rest of South America Measles Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.3 Mumps
- 19.8.5.3.1 Rest of South America Mumps Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.4 Varicella
- 19.8.5.4.1 Rest of South America Varicella Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.5 DPT
- 19.8.5.5.1 Rest of South America DPT Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.6 Hepatitis
- 19.8.5.6.1 Rest of South America Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.7 Influenza
- 19.8.5.7.1 Rest of South America Influenza Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.8 Typhoid
- 19.8.5.8.1 Rest of South America Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.9 Meningococcal
- 19.8.5.9.1 Rest of South America Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.10 Rabies
- 19.8.5.10.1 Rest of South America Rabies Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.11 Japanese Encephalitis
- 19.8.5.11.1 Rest of South America Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.12 Yellow Fever
- 19.8.5.12.1 Rest of South America Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.13 Others
- 19.8.5.13.1 Rest of South America Others Market Share and Revenue (USD Million) for 2018-2030
- 19.8.5.1 Pneumococcal Disease
- 19.8.6 Rest of South America Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 19.8.6.1 Injectable
- 19.8.6.1.1 Rest of South America Injectable Market Share and Revenue (USD Million) for 2018-2030
- 19.8.6.2 Oral
- 19.8.6.2.1 Rest of South America Oral Market Share and Revenue (USD Million) for 2018-2030
- 19.8.6.3 Nasal
- 19.8.6.3.1 Rest of South America Nasal Market Share and Revenue (USD Million) for 2018-2030
- 19.8.6.1 Injectable
- 19.8.1 Rest of South America Vaccines Market (USD Million) by Type (2018-2030)
- 20.1 Middle East and Africa
- 20.1.1 Middle East and Africa Vaccines Market Trends and Analysis
- 20.1.2 Middle East and Africa Vaccines Market by Country, 2018-2030
- 20.1.3 Middle East and Africa Vaccines Market Attractiveness Analysis by Country
- 20.2 Middle East and Africa Vaccines Market Size (2018-2030)
- 20.2.1 Middle East and Africa Vaccines Market (USD Million) by Type (2018-2030)
- 20.2.1.1 Combination Vaccines
- 20.2.1.1.1 Middle East and Africa Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.1.2 Monovaccines
- 20.2.1.2.1 Middle East and Africa Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.1.1 Combination Vaccines
- 20.2.2 Middle East and Africa Vaccines Market (USD Million) by Application (2018-2030)
- 20.2.2.1 Community Hospitals
- 20.2.2.1.1 Middle East and Africa Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.2.2.2 Hospitals
- 20.2.2.2.1 Middle East and Africa Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.2.2.3 Specialty Centres
- 20.2.2.3.1 Middle East and Africa Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.2.2.4 Clinics
- 20.2.2.4.1 Middle East and Africa Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.2.2.5 Others
- 20.2.2.5.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 20.2.2.1 Community Hospitals
- 20.2.3 Middle East and Africa Vaccines Market (USD Million) by Technology (2018-2030)
- 20.2.3.1 Recombinant Vaccines
- 20.2.3.1.1 Middle East and Africa Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.3.2 Conjugate Vaccines
- 20.2.3.2.1 Middle East and Africa Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.3.3 Live-Attenuated Vaccines
- 20.2.3.3.1 Middle East and Africa Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.3.4 Inactivated Vaccines
- 20.2.3.4.1 Middle East and Africa Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.3.5 Toxoid Vaccines
- 20.2.3.5.1 Middle East and Africa Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.2.3.1 Recombinant Vaccines
- 20.2.4 Middle East and Africa Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.2.4.1 Pediatric Vaccine
- 20.2.4.1.1 Middle East and Africa Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.2.4.2 Adult Vaccine
- 20.2.4.2.1 Middle East and Africa Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.2.4.1 Pediatric Vaccine
- 20.2.5 Middle East and Africa Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.2.5.1 Pneumococcal Disease
- 20.2.5.1.1 Middle East and Africa Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.2 Measles
- 20.2.5.2.1 Middle East and Africa Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.3 Mumps
- 20.2.5.3.1 Middle East and Africa Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.4 Varicella
- 20.2.5.4.1 Middle East and Africa Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.5 DPT
- 20.2.5.5.1 Middle East and Africa DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.6 Hepatitis
- 20.2.5.6.1 Middle East and Africa Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.7 Influenza
- 20.2.5.7.1 Middle East and Africa Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.8 Typhoid
- 20.2.5.8.1 Middle East and Africa Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.9 Meningococcal
- 20.2.5.9.1 Middle East and Africa Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.10 Rabies
- 20.2.5.10.1 Middle East and Africa Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.11 Japanese Encephalitis
- 20.2.5.11.1 Middle East and Africa Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.12 Yellow Fever
- 20.2.5.12.1 Middle East and Africa Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.13 Others
- 20.2.5.13.1 Middle East and Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 20.2.5.1 Pneumococcal Disease
- 20.2.6 Middle East and Africa Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.2.6.1 Injectable
- 20.2.6.1.1 Middle East and Africa Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.2.6.2 Oral
- 20.2.6.2.1 Middle East and Africa Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.2.6.3 Nasal
- 20.2.6.3.1 Middle East and Africa Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.2.6.1 Injectable
- 20.2.1 Middle East and Africa Vaccines Market (USD Million) by Type (2018-2030)
- 20.3 Saudi Arabia Vaccines Market Size (2018-2030)
- 20.3.1 Saudi Arabia Vaccines Market (USD Million) by Type (2018-2030)
- 20.3.1.1 Combination Vaccines
- 20.3.1.1.1 Saudi Arabia Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.1.2 Monovaccines
- 20.3.1.2.1 Saudi Arabia Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.1.1 Combination Vaccines
- 20.3.2 Saudi Arabia Vaccines Market (USD Million) by Application (2018-2030)
- 20.3.2.1 Community Hospitals
- 20.3.2.1.1 Saudi Arabia Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.3.2.2 Hospitals
- 20.3.2.2.1 Saudi Arabia Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.3.2.3 Specialty Centres
- 20.3.2.3.1 Saudi Arabia Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.3.2.4 Clinics
- 20.3.2.4.1 Saudi Arabia Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.3.2.5 Others
- 20.3.2.5.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 20.3.2.1 Community Hospitals
- 20.3.3 Saudi Arabia Vaccines Market (USD Million) by Technology (2018-2030)
- 20.3.3.1 Recombinant Vaccines
- 20.3.3.1.1 Saudi Arabia Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.3.2 Conjugate Vaccines
- 20.3.3.2.1 Saudi Arabia Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.3.3 Live-Attenuated Vaccines
- 20.3.3.3.1 Saudi Arabia Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.3.4 Inactivated Vaccines
- 20.3.3.4.1 Saudi Arabia Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.3.5 Toxoid Vaccines
- 20.3.3.5.1 Saudi Arabia Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.3.3.1 Recombinant Vaccines
- 20.3.4 Saudi Arabia Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.3.4.1 Pediatric Vaccine
- 20.3.4.1.1 Saudi Arabia Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.3.4.2 Adult Vaccine
- 20.3.4.2.1 Saudi Arabia Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.3.4.1 Pediatric Vaccine
- 20.3.5 Saudi Arabia Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.3.5.1 Pneumococcal Disease
- 20.3.5.1.1 Saudi Arabia Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.2 Measles
- 20.3.5.2.1 Saudi Arabia Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.3 Mumps
- 20.3.5.3.1 Saudi Arabia Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.4 Varicella
- 20.3.5.4.1 Saudi Arabia Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.5 DPT
- 20.3.5.5.1 Saudi Arabia DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.6 Hepatitis
- 20.3.5.6.1 Saudi Arabia Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.7 Influenza
- 20.3.5.7.1 Saudi Arabia Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.8 Typhoid
- 20.3.5.8.1 Saudi Arabia Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.9 Meningococcal
- 20.3.5.9.1 Saudi Arabia Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.10 Rabies
- 20.3.5.10.1 Saudi Arabia Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.11 Japanese Encephalitis
- 20.3.5.11.1 Saudi Arabia Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.12 Yellow Fever
- 20.3.5.12.1 Saudi Arabia Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.13 Others
- 20.3.5.13.1 Saudi Arabia Others Market Share and Revenue (USD Million) for 2018-2030
- 20.3.5.1 Pneumococcal Disease
- 20.3.6 Saudi Arabia Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.3.6.1 Injectable
- 20.3.6.1.1 Saudi Arabia Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.3.6.2 Oral
- 20.3.6.2.1 Saudi Arabia Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.3.6.3 Nasal
- 20.3.6.3.1 Saudi Arabia Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.3.6.1 Injectable
- 20.3.1 Saudi Arabia Vaccines Market (USD Million) by Type (2018-2030)
- 20.4 Turkey Vaccines Market Size (2018-2030)
- 20.4.1 Turkey Vaccines Market (USD Million) by Type (2018-2030)
- 20.4.1.1 Combination Vaccines
- 20.4.1.1.1 Turkey Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.1.2 Monovaccines
- 20.4.1.2.1 Turkey Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.1.1 Combination Vaccines
- 20.4.2 Turkey Vaccines Market (USD Million) by Application (2018-2030)
- 20.4.2.1 Community Hospitals
- 20.4.2.1.1 Turkey Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.4.2.2 Hospitals
- 20.4.2.2.1 Turkey Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.4.2.3 Specialty Centres
- 20.4.2.3.1 Turkey Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.4.2.4 Clinics
- 20.4.2.4.1 Turkey Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.4.2.5 Others
- 20.4.2.5.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 20.4.2.1 Community Hospitals
- 20.4.3 Turkey Vaccines Market (USD Million) by Technology (2018-2030)
- 20.4.3.1 Recombinant Vaccines
- 20.4.3.1.1 Turkey Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.3.2 Conjugate Vaccines
- 20.4.3.2.1 Turkey Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.3.3 Live-Attenuated Vaccines
- 20.4.3.3.1 Turkey Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.3.4 Inactivated Vaccines
- 20.4.3.4.1 Turkey Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.3.5 Toxoid Vaccines
- 20.4.3.5.1 Turkey Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.4.3.1 Recombinant Vaccines
- 20.4.4 Turkey Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.4.4.1 Pediatric Vaccine
- 20.4.4.1.1 Turkey Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.4.4.2 Adult Vaccine
- 20.4.4.2.1 Turkey Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.4.4.1 Pediatric Vaccine
- 20.4.5 Turkey Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.4.5.1 Pneumococcal Disease
- 20.4.5.1.1 Turkey Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.2 Measles
- 20.4.5.2.1 Turkey Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.3 Mumps
- 20.4.5.3.1 Turkey Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.4 Varicella
- 20.4.5.4.1 Turkey Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.5 DPT
- 20.4.5.5.1 Turkey DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.6 Hepatitis
- 20.4.5.6.1 Turkey Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.7 Influenza
- 20.4.5.7.1 Turkey Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.8 Typhoid
- 20.4.5.8.1 Turkey Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.9 Meningococcal
- 20.4.5.9.1 Turkey Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.10 Rabies
- 20.4.5.10.1 Turkey Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.11 Japanese Encephalitis
- 20.4.5.11.1 Turkey Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.12 Yellow Fever
- 20.4.5.12.1 Turkey Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.13 Others
- 20.4.5.13.1 Turkey Others Market Share and Revenue (USD Million) for 2018-2030
- 20.4.5.1 Pneumococcal Disease
- 20.4.6 Turkey Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.4.6.1 Injectable
- 20.4.6.1.1 Turkey Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.4.6.2 Oral
- 20.4.6.2.1 Turkey Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.4.6.3 Nasal
- 20.4.6.3.1 Turkey Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.4.6.1 Injectable
- 20.4.1 Turkey Vaccines Market (USD Million) by Type (2018-2030)
- 20.5 Nigeria Vaccines Market Size (2018-2030)
- 20.5.1 Nigeria Vaccines Market (USD Million) by Type (2018-2030)
- 20.5.1.1 Combination Vaccines
- 20.5.1.1.1 Nigeria Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.1.2 Monovaccines
- 20.5.1.2.1 Nigeria Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.1.1 Combination Vaccines
- 20.5.2 Nigeria Vaccines Market (USD Million) by Application (2018-2030)
- 20.5.2.1 Community Hospitals
- 20.5.2.1.1 Nigeria Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.5.2.2 Hospitals
- 20.5.2.2.1 Nigeria Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.5.2.3 Specialty Centres
- 20.5.2.3.1 Nigeria Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.5.2.4 Clinics
- 20.5.2.4.1 Nigeria Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.5.2.5 Others
- 20.5.2.5.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 20.5.2.1 Community Hospitals
- 20.5.3 Nigeria Vaccines Market (USD Million) by Technology (2018-2030)
- 20.5.3.1 Recombinant Vaccines
- 20.5.3.1.1 Nigeria Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.3.2 Conjugate Vaccines
- 20.5.3.2.1 Nigeria Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.3.3 Live-Attenuated Vaccines
- 20.5.3.3.1 Nigeria Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.3.4 Inactivated Vaccines
- 20.5.3.4.1 Nigeria Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.3.5 Toxoid Vaccines
- 20.5.3.5.1 Nigeria Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.5.3.1 Recombinant Vaccines
- 20.5.4 Nigeria Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.5.4.1 Pediatric Vaccine
- 20.5.4.1.1 Nigeria Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.5.4.2 Adult Vaccine
- 20.5.4.2.1 Nigeria Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.5.4.1 Pediatric Vaccine
- 20.5.5 Nigeria Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.5.5.1 Pneumococcal Disease
- 20.5.5.1.1 Nigeria Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.2 Measles
- 20.5.5.2.1 Nigeria Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.3 Mumps
- 20.5.5.3.1 Nigeria Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.4 Varicella
- 20.5.5.4.1 Nigeria Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.5 DPT
- 20.5.5.5.1 Nigeria DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.6 Hepatitis
- 20.5.5.6.1 Nigeria Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.7 Influenza
- 20.5.5.7.1 Nigeria Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.8 Typhoid
- 20.5.5.8.1 Nigeria Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.9 Meningococcal
- 20.5.5.9.1 Nigeria Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.10 Rabies
- 20.5.5.10.1 Nigeria Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.11 Japanese Encephalitis
- 20.5.5.11.1 Nigeria Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.12 Yellow Fever
- 20.5.5.12.1 Nigeria Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.13 Others
- 20.5.5.13.1 Nigeria Others Market Share and Revenue (USD Million) for 2018-2030
- 20.5.5.1 Pneumococcal Disease
- 20.5.6 Nigeria Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.5.6.1 Injectable
- 20.5.6.1.1 Nigeria Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.5.6.2 Oral
- 20.5.6.2.1 Nigeria Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.5.6.3 Nasal
- 20.5.6.3.1 Nigeria Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.5.6.1 Injectable
- 20.5.1 Nigeria Vaccines Market (USD Million) by Type (2018-2030)
- 20.6 UAE Vaccines Market Size (2018-2030)
- 20.6.1 UAE Vaccines Market (USD Million) by Type (2018-2030)
- 20.6.1.1 Combination Vaccines
- 20.6.1.1.1 UAE Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.1.2 Monovaccines
- 20.6.1.2.1 UAE Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.1.1 Combination Vaccines
- 20.6.2 UAE Vaccines Market (USD Million) by Application (2018-2030)
- 20.6.2.1 Community Hospitals
- 20.6.2.1.1 UAE Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.6.2.2 Hospitals
- 20.6.2.2.1 UAE Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.6.2.3 Specialty Centres
- 20.6.2.3.1 UAE Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.6.2.4 Clinics
- 20.6.2.4.1 UAE Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.6.2.5 Others
- 20.6.2.5.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 20.6.2.1 Community Hospitals
- 20.6.3 UAE Vaccines Market (USD Million) by Technology (2018-2030)
- 20.6.3.1 Recombinant Vaccines
- 20.6.3.1.1 UAE Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.3.2 Conjugate Vaccines
- 20.6.3.2.1 UAE Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.3.3 Live-Attenuated Vaccines
- 20.6.3.3.1 UAE Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.3.4 Inactivated Vaccines
- 20.6.3.4.1 UAE Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.3.5 Toxoid Vaccines
- 20.6.3.5.1 UAE Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.6.3.1 Recombinant Vaccines
- 20.6.4 UAE Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.6.4.1 Pediatric Vaccine
- 20.6.4.1.1 UAE Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.6.4.2 Adult Vaccine
- 20.6.4.2.1 UAE Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.6.4.1 Pediatric Vaccine
- 20.6.5 UAE Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.6.5.1 Pneumococcal Disease
- 20.6.5.1.1 UAE Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.2 Measles
- 20.6.5.2.1 UAE Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.3 Mumps
- 20.6.5.3.1 UAE Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.4 Varicella
- 20.6.5.4.1 UAE Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.5 DPT
- 20.6.5.5.1 UAE DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.6 Hepatitis
- 20.6.5.6.1 UAE Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.7 Influenza
- 20.6.5.7.1 UAE Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.8 Typhoid
- 20.6.5.8.1 UAE Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.9 Meningococcal
- 20.6.5.9.1 UAE Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.10 Rabies
- 20.6.5.10.1 UAE Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.11 Japanese Encephalitis
- 20.6.5.11.1 UAE Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.12 Yellow Fever
- 20.6.5.12.1 UAE Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.13 Others
- 20.6.5.13.1 UAE Others Market Share and Revenue (USD Million) for 2018-2030
- 20.6.5.1 Pneumococcal Disease
- 20.6.6 UAE Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.6.6.1 Injectable
- 20.6.6.1.1 UAE Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.6.6.2 Oral
- 20.6.6.2.1 UAE Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.6.6.3 Nasal
- 20.6.6.3.1 UAE Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.6.6.1 Injectable
- 20.6.1 UAE Vaccines Market (USD Million) by Type (2018-2030)
- 20.7 Egypt Vaccines Market Size (2018-2030)
- 20.7.1 Egypt Vaccines Market (USD Million) by Type (2018-2030)
- 20.7.1.1 Combination Vaccines
- 20.7.1.1.1 Egypt Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.1.2 Monovaccines
- 20.7.1.2.1 Egypt Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.1.1 Combination Vaccines
- 20.7.2 Egypt Vaccines Market (USD Million) by Application (2018-2030)
- 20.7.2.1 Community Hospitals
- 20.7.2.1.1 Egypt Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.7.2.2 Hospitals
- 20.7.2.2.1 Egypt Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.7.2.3 Specialty Centres
- 20.7.2.3.1 Egypt Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.7.2.4 Clinics
- 20.7.2.4.1 Egypt Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.7.2.5 Others
- 20.7.2.5.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 20.7.2.1 Community Hospitals
- 20.7.3 Egypt Vaccines Market (USD Million) by Technology (2018-2030)
- 20.7.3.1 Recombinant Vaccines
- 20.7.3.1.1 Egypt Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.3.2 Conjugate Vaccines
- 20.7.3.2.1 Egypt Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.3.3 Live-Attenuated Vaccines
- 20.7.3.3.1 Egypt Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.3.4 Inactivated Vaccines
- 20.7.3.4.1 Egypt Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.3.5 Toxoid Vaccines
- 20.7.3.5.1 Egypt Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.7.3.1 Recombinant Vaccines
- 20.7.4 Egypt Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.7.4.1 Pediatric Vaccine
- 20.7.4.1.1 Egypt Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.7.4.2 Adult Vaccine
- 20.7.4.2.1 Egypt Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.7.4.1 Pediatric Vaccine
- 20.7.5 Egypt Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.7.5.1 Pneumococcal Disease
- 20.7.5.1.1 Egypt Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.2 Measles
- 20.7.5.2.1 Egypt Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.3 Mumps
- 20.7.5.3.1 Egypt Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.4 Varicella
- 20.7.5.4.1 Egypt Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.5 DPT
- 20.7.5.5.1 Egypt DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.6 Hepatitis
- 20.7.5.6.1 Egypt Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.7 Influenza
- 20.7.5.7.1 Egypt Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.8 Typhoid
- 20.7.5.8.1 Egypt Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.9 Meningococcal
- 20.7.5.9.1 Egypt Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.10 Rabies
- 20.7.5.10.1 Egypt Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.11 Japanese Encephalitis
- 20.7.5.11.1 Egypt Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.12 Yellow Fever
- 20.7.5.12.1 Egypt Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.13 Others
- 20.7.5.13.1 Egypt Others Market Share and Revenue (USD Million) for 2018-2030
- 20.7.5.1 Pneumococcal Disease
- 20.7.6 Egypt Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.7.6.1 Injectable
- 20.7.6.1.1 Egypt Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.7.6.2 Oral
- 20.7.6.2.1 Egypt Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.7.6.3 Nasal
- 20.7.6.3.1 Egypt Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.7.6.1 Injectable
- 20.7.1 Egypt Vaccines Market (USD Million) by Type (2018-2030)
- 20.8 South Africa Vaccines Market Size (2018-2030)
- 20.8.1 South Africa Vaccines Market (USD Million) by Type (2018-2030)
- 20.8.1.1 Combination Vaccines
- 20.8.1.1.1 South Africa Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.1.2 Monovaccines
- 20.8.1.2.1 South Africa Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.1.1 Combination Vaccines
- 20.8.2 South Africa Vaccines Market (USD Million) by Application (2018-2030)
- 20.8.2.1 Community Hospitals
- 20.8.2.1.1 South Africa Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.8.2.2 Hospitals
- 20.8.2.2.1 South Africa Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.8.2.3 Specialty Centres
- 20.8.2.3.1 South Africa Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.8.2.4 Clinics
- 20.8.2.4.1 South Africa Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.8.2.5 Others
- 20.8.2.5.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 20.8.2.1 Community Hospitals
- 20.8.3 South Africa Vaccines Market (USD Million) by Technology (2018-2030)
- 20.8.3.1 Recombinant Vaccines
- 20.8.3.1.1 South Africa Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.3.2 Conjugate Vaccines
- 20.8.3.2.1 South Africa Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.3.3 Live-Attenuated Vaccines
- 20.8.3.3.1 South Africa Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.3.4 Inactivated Vaccines
- 20.8.3.4.1 South Africa Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.3.5 Toxoid Vaccines
- 20.8.3.5.1 South Africa Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.8.3.1 Recombinant Vaccines
- 20.8.4 South Africa Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.8.4.1 Pediatric Vaccine
- 20.8.4.1.1 South Africa Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.8.4.2 Adult Vaccine
- 20.8.4.2.1 South Africa Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.8.4.1 Pediatric Vaccine
- 20.8.5 South Africa Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.8.5.1 Pneumococcal Disease
- 20.8.5.1.1 South Africa Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.2 Measles
- 20.8.5.2.1 South Africa Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.3 Mumps
- 20.8.5.3.1 South Africa Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.4 Varicella
- 20.8.5.4.1 South Africa Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.5 DPT
- 20.8.5.5.1 South Africa DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.6 Hepatitis
- 20.8.5.6.1 South Africa Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.7 Influenza
- 20.8.5.7.1 South Africa Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.8 Typhoid
- 20.8.5.8.1 South Africa Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.9 Meningococcal
- 20.8.5.9.1 South Africa Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.10 Rabies
- 20.8.5.10.1 South Africa Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.11 Japanese Encephalitis
- 20.8.5.11.1 South Africa Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.12 Yellow Fever
- 20.8.5.12.1 South Africa Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.13 Others
- 20.8.5.13.1 South Africa Others Market Share and Revenue (USD Million) for 2018-2030
- 20.8.5.1 Pneumococcal Disease
- 20.8.6 South Africa Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.8.6.1 Injectable
- 20.8.6.1.1 South Africa Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.8.6.2 Oral
- 20.8.6.2.1 South Africa Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.8.6.3 Nasal
- 20.8.6.3.1 South Africa Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.8.6.1 Injectable
- 20.8.1 South Africa Vaccines Market (USD Million) by Type (2018-2030)
- 20.9 GCC Countries Vaccines Market Size (2018-2030)
- 20.9.1 GCC Countries Vaccines Market (USD Million) by Type (2018-2030)
- 20.9.1.1 Combination Vaccines
- 20.9.1.1.1 GCC Countries Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.1.2 Monovaccines
- 20.9.1.2.1 GCC Countries Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.1.1 Combination Vaccines
- 20.9.2 GCC Countries Vaccines Market (USD Million) by Application (2018-2030)
- 20.9.2.1 Community Hospitals
- 20.9.2.1.1 GCC Countries Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.9.2.2 Hospitals
- 20.9.2.2.1 GCC Countries Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.9.2.3 Specialty Centres
- 20.9.2.3.1 GCC Countries Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.9.2.4 Clinics
- 20.9.2.4.1 GCC Countries Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.9.2.5 Others
- 20.9.2.5.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 20.9.2.1 Community Hospitals
- 20.9.3 GCC Countries Vaccines Market (USD Million) by Technology (2018-2030)
- 20.9.3.1 Recombinant Vaccines
- 20.9.3.1.1 GCC Countries Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.3.2 Conjugate Vaccines
- 20.9.3.2.1 GCC Countries Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.3.3 Live-Attenuated Vaccines
- 20.9.3.3.1 GCC Countries Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.3.4 Inactivated Vaccines
- 20.9.3.4.1 GCC Countries Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.3.5 Toxoid Vaccines
- 20.9.3.5.1 GCC Countries Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.9.3.1 Recombinant Vaccines
- 20.9.4 GCC Countries Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.9.4.1 Pediatric Vaccine
- 20.9.4.1.1 GCC Countries Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.9.4.2 Adult Vaccine
- 20.9.4.2.1 GCC Countries Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.9.4.1 Pediatric Vaccine
- 20.9.5 GCC Countries Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.9.5.1 Pneumococcal Disease
- 20.9.5.1.1 GCC Countries Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.2 Measles
- 20.9.5.2.1 GCC Countries Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.3 Mumps
- 20.9.5.3.1 GCC Countries Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.4 Varicella
- 20.9.5.4.1 GCC Countries Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.5 DPT
- 20.9.5.5.1 GCC Countries DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.6 Hepatitis
- 20.9.5.6.1 GCC Countries Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.7 Influenza
- 20.9.5.7.1 GCC Countries Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.8 Typhoid
- 20.9.5.8.1 GCC Countries Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.9 Meningococcal
- 20.9.5.9.1 GCC Countries Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.10 Rabies
- 20.9.5.10.1 GCC Countries Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.11 Japanese Encephalitis
- 20.9.5.11.1 GCC Countries Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.12 Yellow Fever
- 20.9.5.12.1 GCC Countries Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.13 Others
- 20.9.5.13.1 GCC Countries Others Market Share and Revenue (USD Million) for 2018-2030
- 20.9.5.1 Pneumococcal Disease
- 20.9.6 GCC Countries Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.9.6.1 Injectable
- 20.9.6.1.1 GCC Countries Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.9.6.2 Oral
- 20.9.6.2.1 GCC Countries Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.9.6.3 Nasal
- 20.9.6.3.1 GCC Countries Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.9.6.1 Injectable
- 20.9.1 GCC Countries Vaccines Market (USD Million) by Type (2018-2030)
- 20.10 Rest of MEA Vaccines Market Size (2018-2030)
- 20.10.1 Rest of MEA Vaccines Market (USD Million) by Type (2018-2030)
- 20.10.1.1 Combination Vaccines
- 20.10.1.1.1 Rest of MEA Combination Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.1.2 Monovaccines
- 20.10.1.2.1 Rest of MEA Monovaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.1.1 Combination Vaccines
- 20.10.2 Rest of MEA Vaccines Market (USD Million) by Application (2018-2030)
- 20.10.2.1 Community Hospitals
- 20.10.2.1.1 Rest of MEA Community Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.10.2.2 Hospitals
- 20.10.2.2.1 Rest of MEA Hospitals Market Share and Revenue (USD Million) for 2018-2030
- 20.10.2.3 Specialty Centres
- 20.10.2.3.1 Rest of MEA Specialty Centres Market Share and Revenue (USD Million) for 2018-2030
- 20.10.2.4 Clinics
- 20.10.2.4.1 Rest of MEA Clinics Market Share and Revenue (USD Million) for 2018-2030
- 20.10.2.5 Others
- 20.10.2.5.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 20.10.2.1 Community Hospitals
- 20.10.3 Rest of MEA Vaccines Market (USD Million) by Technology (2018-2030)
- 20.10.3.1 Recombinant Vaccines
- 20.10.3.1.1 Rest of MEA Recombinant Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.3.2 Conjugate Vaccines
- 20.10.3.2.1 Rest of MEA Conjugate Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.3.3 Live-Attenuated Vaccines
- 20.10.3.3.1 Rest of MEA Live-Attenuated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.3.4 Inactivated Vaccines
- 20.10.3.4.1 Rest of MEA Inactivated Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.3.5 Toxoid Vaccines
- 20.10.3.5.1 Rest of MEA Toxoid Vaccines Market Share and Revenue (USD Million) for 2018-2030
- 20.10.3.1 Recombinant Vaccines
- 20.10.4 Rest of MEA Vaccines Market (USD Million) by Age Group (2018-2030)
- 20.10.4.1 Pediatric Vaccine
- 20.10.4.1.1 Rest of MEA Pediatric Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.10.4.2 Adult Vaccine
- 20.10.4.2.1 Rest of MEA Adult Vaccine Market Share and Revenue (USD Million) for 2018-2030
- 20.10.4.1 Pediatric Vaccine
- 20.10.5 Rest of MEA Vaccines Market (USD Million) by Type of Diseases (2018-2030)
- 20.10.5.1 Pneumococcal Disease
- 20.10.5.1.1 Rest of MEA Pneumococcal Disease Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.2 Measles
- 20.10.5.2.1 Rest of MEA Measles Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.3 Mumps
- 20.10.5.3.1 Rest of MEA Mumps Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.4 Varicella
- 20.10.5.4.1 Rest of MEA Varicella Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.5 DPT
- 20.10.5.5.1 Rest of MEA DPT Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.6 Hepatitis
- 20.10.5.6.1 Rest of MEA Hepatitis Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.7 Influenza
- 20.10.5.7.1 Rest of MEA Influenza Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.8 Typhoid
- 20.10.5.8.1 Rest of MEA Typhoid Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.9 Meningococcal
- 20.10.5.9.1 Rest of MEA Meningococcal Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.10 Rabies
- 20.10.5.10.1 Rest of MEA Rabies Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.11 Japanese Encephalitis
- 20.10.5.11.1 Rest of MEA Japanese Encephalitis Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.12 Yellow Fever
- 20.10.5.12.1 Rest of MEA Yellow Fever Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.13 Others
- 20.10.5.13.1 Rest of MEA Others Market Share and Revenue (USD Million) for 2018-2030
- 20.10.5.1 Pneumococcal Disease
- 20.10.6 Rest of MEA Vaccines Market (USD Million) by Route of Administration (2018-2030)
- 20.10.6.1 Injectable
- 20.10.6.1.1 Rest of MEA Injectable Market Share and Revenue (USD Million) for 2018-2030
- 20.10.6.2 Oral
- 20.10.6.2.1 Rest of MEA Oral Market Share and Revenue (USD Million) for 2018-2030
- 20.10.6.3 Nasal
- 20.10.6.3.1 Rest of MEA Nasal Market Share and Revenue (USD Million) for 2018-2030
- 20.10.6.1 Injectable
- 20.10.1 Rest of MEA Vaccines Market (USD Million) by Type (2018-2030)
- 21.1 Key Takeaways
- 21.2 Analyst Point of View
Segmentation Level Customization | |
Global level Data Customization | |
Region level Data Customization | |
Country level Data Customization | |
Company Level | |
Additional Data Analysis | |
Additional Qualitative Data | |
Additional Quantitative Data | |
Service Level Customization | Report Format Alteration |
We have various report editions of Vaccines Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Vaccines Market Analysis
Global Vaccines Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Vaccines Industry growth. Vaccines market has been segmented with the help of its Type, Application Technology, and others. Vaccines market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Report scope is customizable as we have a huge database of Vaccines industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Major Type Analysed | |
Major Application Analysed | |
Major Technology Analysed | Recombinant Vaccines, Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines |
Major Age Group Analysed | Pediatric Vaccine, Adult Vaccine |
Major Type of Diseases Analysed | Pneumococcal Disease, Measles, Mumps, Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others |
Major Route of Administration Analysed | Injectable, Oral, Nasal |
Top Manufacturers Disclosed | |
Global, Regional and Country Analysis |
|
Key Qualitative Information Covered |
|
Type Segment Analysis of Vaccines Market
Based on present and future trends, the market size is estimated from 2018 to 2030. Moreover, study also provides quantitative and qualitative analysis of each type to understand the driving factors for the fastest growing type segment for Vaccines market.
Type of Vaccines analyzed in this report are as follows:
- Combination Vaccines
- Monovaccines
Vaccines Market Share (%) by Type in 2018-2030
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Vaccines Industry. Request a Free Sample PDF!
Application Segment Analysis of Vaccines Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Vaccines from 2018 to 2030. This will also help to analyze the demand for Vaccines across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Application of Vaccines are:
- Community Hospitals
- Hospitals
- Specialty Centres
- Clinics
- Others
Vaccines Market Share (%) by Application in 2018-2030
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Vaccines market report 2023 Edition by contacting our team.
Vaccines Technology Segment Analysis
- Recombinant Vaccines
- Conjugate Vaccines
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
Vaccines Age Group Segment Analysis
- Pediatric Vaccine
- Adult Vaccine
Vaccines Type of Diseases Segment Analysis
- Pneumococcal Disease
- Measles
- Mumps
- Varicella
- DPT
- Hepatitis
- Influenza
- Typhoid
- Meningococcal
- Rabies
- Japanese Encephalitis
- Yellow Fever
- Others
Vaccines Route of Administration Segment Analysis
- Injectable
- Oral
- Nasal
The North America Vaccines Market dominates the overall market!
North America is estimated as the largest market for vaccines and is projected to grow with the highest CAGR during the forecast period, owing to the increased research and development investment in vaccines, strong awareness about vaccines, and the presence of major manufacturers. On the other hand, the APAC region is expected to witness tremendous growth in the market. This is due to the growing population in developing economies like India, China, and others, increasing healthcare expenditure, and government initiatives regarding vaccines in rural areas.
Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Vaccines Market Share (%) by Region (2018-2030)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Vaccines Industry News:
Bharat Biotech: India launched its first nasal Covid vaccine (January 2023)
Made by Bharat Biotech, iNCOVACC is administered in the form of drops and stimulates an immune response in the tissues that line the nasal cavity. The vaccine will cost 800 rupees ($10; £8) per dose in private hospitals and 325 rupees per dose in government hospitals.
Top Companies Market Share in Vaccines Industry: (In no particular order of Rank)
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune  LLC
- J&J Crucell
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Vaccines Market is witnessing significant growth in the near future.
In 2022, the Combination Vaccines segment accounted for noticeable share of global Vaccines Market and is projected to experience significant growth in the near future.
The Community Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies GSK, Merck and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Author's Detail
Smruti Ransingh, LinkedIn
Research Analyst at Cognitive Market Research
Smruti Ransingh, holding a Bachelor's degree in Electronics and Telecommunication Engineering, is a seasoned market researcher in the Electronics & Electrical industry. Over the years, she has collaborated with key players in the field, aiding them in identifying market prospects and offering effective strategic solutions. Her proficiency lies in integrating qualitative and quantitative research techniques to conduct Market Assessments that steer business choices.
Key Questions Answered By Vaccines Market Report 2023
Why Combination Vaccines have a significant impact on Vaccines market? |
What are the key factors affecting the Combination Vaccines and Monovaccines of Vaccines Market? |
What is the CAGR/Growth Rate of Community Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Vaccines Market? |
Which region is expected to dominate the global Vaccines Market within the forecast period? |
Frequently Asked Questions
Related Reports
- Measures to Explore Untapped Market
- Understanding Market Dynamics
- Understanding Changing Economics
- Competitors Market Share
- Global/Region/Country Level Analysis
- Identify Upcoming End Use Industries
- Global Price Trend Analysis
- Value Chain Analysis
- Customer Sentiment/Need Analysis
- Identification of Key Growth Segments
- Industry Upstream and Downstream Analysis
- Raw Material Sourcing and Cost Analysis
- Identify Key Customers Across Globe
- Concept Development and Market Testing
- Merger-Acquisition Strategy
- The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
- This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.
- This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
- The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.
- Our objective for the Vaccines market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
- To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.
- To identify the Vaccines market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
- To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
- To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
- To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
- To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.
- Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
- We provide market revenue share not only for Public listed companies but also the privately listed companies.
- Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
- We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
- Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
- Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.
Read more